{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["anticancer natural prodrugs", "cancer targeting", "controlled release", "drug delivery systems", "mesoporous silica nanoparticles", "nanoformulations/nanomedicine applications", "natural products"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33499150", "DateRevised": {"Year": "2024", "Month": "03", "Day": "31"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "01", "Day": "22"}], "Language": ["eng"], "ELocationID": ["143", "10.3390/pharmaceutics13020143"], "Journal": {"ISSN": "1999-4923", "JournalIssue": {"Volume": "13", "Issue": "2", "PubDate": {"Year": "2021", "Month": "Jan", "Day": "22"}}, "Title": "Pharmaceutics", "ISOAbbreviation": "Pharmaceutics"}, "ArticleTitle": "Delivery of Natural Agents by Means of Mesoporous Silica Nanospheres as a Promising Anticancer Strategy.", "Abstract": {"AbstractText": ["Natural prodrugs derived from different natural origins (e.g., medicinal plants, microbes, animals) have a long history in traditional medicine. They exhibit a broad range of pharmacological activities, including anticancer effects in vitro and in vivo. They have potential as safe, cost-effective treatments with few side effects, but are lacking in solubility, bioavailability, specific targeting and have short half-lives. These are barriers to clinical application. Nanomedicine has the potential to offer solutions to circumvent these limitations and allow the use of natural pro-drugs in cancer therapy. Mesoporous silica nanoparticles (MSNs) of various morphology have attracted considerable attention in the search for targeted drug delivery systems. MSNs are characterized by chemical stability, easy synthesis and functionalization, large surface area, tunable pore sizes and volumes, good biocompatibility, controlled drug release under different conditions, and high drug-loading capacity, enabling multifunctional purposes. In vivo pre-clinical evaluations, a significant majority of results indicate the safety profile of MSNs if they are synthesized in an optimized way. Here, we present an overview of synthesis methods, possible surface functionalization, cellular uptake, biodistribution, toxicity, loading strategies, delivery designs with controlled release, and cancer targeting and discuss the future of anticancer nanotechnology-based natural prodrug delivery systems."]}, "AuthorList": [{"Identifier": ["0000-0001-8413-6738"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Nanostructures and Nanomedicine, Institute of High Pressure Physics, Polish Academy of Sciences, Sokolowska 29/37, 01-142 Warsaw, Poland."}, {"Identifier": [], "Affiliation": "Medicinal and Aromatic Plants Research Department, Pharmaceutical and Drug Industries Research Division, National Research Centre (NRC), 33 El-Behouth St., Dokki, Giza 12622, Egypt."}], "LastName": "AbouAitah", "ForeName": "Khaled", "Initials": "K"}, {"Identifier": ["0000-0001-8521-0688"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Nanostructures and Nanomedicine, Institute of High Pressure Physics, Polish Academy of Sciences, Sokolowska 29/37, 01-142 Warsaw, Poland."}], "LastName": "Lojkowski", "ForeName": "Witold", "Initials": "W"}], "GrantList": [{"GrantID": "STATUT", "Agency": "Institute of High Pressure Physics, Poland", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceutics", "NlmUniqueID": "101534003", "ISSNLinking": "1999-4923"}, "CoiStatement": "The authors declare no conflict of interest regarding the publication of this paper."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Vallet-Regi M., R\u00e1mila A., del Real R.P., P\u00e9rez-Pariente J. A New Property of MCM-41:\u2009 Drug Delivery System. Chem. Mater. 2001;13:308\u2013311. doi: 10.1021/cm0011559.", "ArticleIdList": ["10.1021/cm0011559"]}, {"Citation": "Kresge C.T., Leonowicz M.E., Roth W.J., Vartuli J.C., Beck J.S. Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature. 1992;359:710\u2013712. doi: 10.1038/359710a0.", "ArticleIdList": ["10.1038/359710a0"]}, {"Citation": "Gon\u00e7alves M.C. Sol-Gel Silica Nanoparticles in Medicine: A Natural Choice. Design, Synthesis and Products. Molecules. 2018;23:2021. doi: 10.3390/molecules23082021.", "ArticleIdList": ["10.3390/molecules23082021", "PMC6222648", "30104542"]}, {"Citation": "Pednekar P.P., Godiyal S.C., Jadhav K.R., Kadam V.J. Chapter 23\u2014Mesoporous silica nanoparticles: A promising multifunctional drug delivery system. In: Ficai A., Grumezescu A.M., editors. Nanostructures for Cancer Therapy. Elsevier; Amsterdam, The Netherlands: 2017. pp. 593\u2013621."}, {"Citation": "Le Hoang Doan T., Mai N.X.D., Matsumoto K., Tamanoi F. Chapter 4\u2014Tumor Targeting and Tumor Growth Inhibition Capability of Mesoporous Silica Nanoparticles in Mouse Models. In: Tamanoi F., editor. The Enzymes. Volume 44. Academic Press; Cambridge, MA, USA: 2018. pp. 61\u201382.", "ArticleIdList": ["30360815"]}, {"Citation": "Mitran R.-A., Deaconu M., Matei C., Berger D. Chapter 11\u2014Mesoporous Silica as Carrier for Drug-Delivery Systems. In: Mohapatra S.S., Ranjan S., Dasgupta N., Mishra R.K., Thomas S., editors. Nanocarriers for Drug Delivery. Elsevier; Amsterdam, The Netherlands: 2019. pp. 351\u2013374."}, {"Citation": "Mekaru H., Lu J., Tamanoi F. Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy. Adv. Drug Deliv. Rev. 2015;95:40\u201349. doi: 10.1016/j.addr.2015.09.009.", "ArticleIdList": ["10.1016/j.addr.2015.09.009", "PMC4663124", "26434537"]}, {"Citation": "Slowing I.I., Vivero-Escoto J.L., Wu C.-W., Lin V.S.Y. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv. Drug Deliv. Rev. 2008;60:1278\u20131288. doi: 10.1016/j.addr.2008.03.012.", "ArticleIdList": ["10.1016/j.addr.2008.03.012", "18514969"]}, {"Citation": "Mamaeva V., Sahlgren C., Lind\u00e9n M. Mesoporous silica nanoparticles in medicine\u2014Recent advances. Adv. Drug Deliv. Rev. 2013;65:689\u2013702. doi: 10.1016/j.addr.2012.07.018.", "ArticleIdList": ["10.1016/j.addr.2012.07.018", "22921598"]}, {"Citation": "Narayan R., Nayak U.Y., Raichur A.M., Garg S. Mesoporous Silica Nanoparticles: A Comprehensive Review on Synthesis and Recent Advances. Pharmaceutics. 2018;10:118. doi: 10.3390/pharmaceutics10030118.", "ArticleIdList": ["10.3390/pharmaceutics10030118", "PMC6160987", "30082647"]}, {"Citation": "Kwon S., Singh R.K., Perez R.A., Abou Neel E.A., Kim H.W., Chrzanowski W. Silica-based mesoporous nanoparticles for controlled drug delivery. J. Tissue Eng. 2013;4:2041731413503357. doi: 10.1177/2041731413503357.", "ArticleIdList": ["10.1177/2041731413503357", "PMC3764983", "24020012"]}, {"Citation": "Liong M., Lu J., Kovochich M., Xia T., Ruehm S.G., Nel A.E., Tamanoi F., Zink J.I. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano. 2008;2:889\u2013896. doi: 10.1021/nn800072t.", "ArticleIdList": ["10.1021/nn800072t", "PMC2751731", "19206485"]}, {"Citation": "P\u00e9rez-Esteve \u00c9., Ruiz-Rico M., de la Torre C., Llorca E., Sancen\u00f3n F., Marcos M.D., Amor\u00f3s P., Guillem C., Mart\u00ednez-M\u00e1\u00f1ez R., Barat J.M. Stability of different mesoporous silica particles during an in vitro digestion. Microporous Mesoporous Mater. 2016;230:196\u2013207. doi: 10.1016/j.micromeso.2016.05.004.", "ArticleIdList": ["10.1016/j.micromeso.2016.05.004"]}, {"Citation": "Riikonen J., Xu W., Lehto V.-P. Mesoporous systems for poorly soluble drugs\u2014Recent trends. Int. J. Pharm. 2018;536:178\u2013186. doi: 10.1016/j.ijpharm.2017.11.054.", "ArticleIdList": ["10.1016/j.ijpharm.2017.11.054", "29183856"]}, {"Citation": "Maleki A., Kettiger H., Schoubben A., Rosenholm J.M., Ambrogi V., Hamidi M. Mesoporous silica materials: From physico-chemical properties to enhanced dissolution of poorly water-soluble drugs. J. Control. Release. 2017;262:329\u2013347. doi: 10.1016/j.jconrel.2017.07.047.", "ArticleIdList": ["10.1016/j.jconrel.2017.07.047", "28778479"]}, {"Citation": "Ambrogi V., Perioli L., Pagano C., Latterini L., Marmottini F., Ricci M., Rossi C. MCM-41 for furosemide dissolution improvement. Microporous Mesoporous Mater. 2012;147:343\u2013349. doi: 10.1016/j.micromeso.2011.07.007.", "ArticleIdList": ["10.1016/j.micromeso.2011.07.007"]}, {"Citation": "Yang G., Li Z., Wu F., Chen M., Wang R., Zhu H., Li Q., Yuan Y. Improving Solubility and Bioavailability of Breviscapine with Mesoporous Silica Nanoparticles Prepared Using Ultrasound-Assisted Solution-Enhanced Dispersion by Supercritical Fluids Method. Int. J. Nanomed. 2020;15:1661\u20131675. doi: 10.2147/IJN.S238337.", "ArticleIdList": ["10.2147/IJN.S238337", "PMC7071864", "32210559"]}, {"Citation": "McCarthy C.A., Ahern R.J., Dontireddy R., Ryan K.B., Crean A.M. Mesoporous silica formulation strategies for drug dissolution enhancement: A review. Expert Opin. Drug Deliv. 2016;13:93\u2013108. doi: 10.1517/17425247.2016.1100165.", "ArticleIdList": ["10.1517/17425247.2016.1100165", "26549623"]}, {"Citation": "Kumar D., Sailaja Chirravuri S.V., Shastri N.R. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: A case study with aceclofenac. Int. J. Pharm. 2014;461:459\u2013468. doi: 10.1016/j.ijpharm.2013.12.017.", "ArticleIdList": ["10.1016/j.ijpharm.2013.12.017", "24368106"]}, {"Citation": "Huang Y., Zhao X., Zu Y., Wang L., Deng Y., Wu M., Wang H. Enhanced Solubility and Bioavailability of Apigenin via Preparation of Solid Dispersions of Mesoporous Silica Nanoparticles. Iran. J. Pharm. Res. 2019;18:168\u2013182.", "ArticleIdList": ["PMC6487423", "31089353"]}, {"Citation": "Zhang Q., Wang X., Li P.-Z., Nguyen K.T., Wang X.-J., Luo Z., Zhang H., Tan N.S., Zhao Y. Biocompatible, Uniform, and Redispersible Mesoporous Silica Nanoparticles for Cancer-Targeted Drug Delivery In Vivo. Adv. Funct. Mater. 2014;24:2450\u20132461. doi: 10.1002/adfm.201302988.", "ArticleIdList": ["10.1002/adfm.201302988"]}, {"Citation": "Argyo C., Weiss V., Br\u00e4uchle C., Bein T. Multifunctional Mesoporous Silica Nanoparticles as a Universal Platform for Drug Delivery. Chem. Mater. 2014;26:435\u2013451. doi: 10.1021/cm402592t.", "ArticleIdList": ["10.1021/cm402592t"]}, {"Citation": "Lu J., Liong M., Li Z., Zink J.I., Tamanoi F. Biocompatibility, Biodistribution, and Drug-Delivery Efficiency of Mesoporous Silica Nanoparticles for Cancer Therapy in Animals. Small. 2010;6:1794\u20131805. doi: 10.1002/smll.201000538.", "ArticleIdList": ["10.1002/smll.201000538", "PMC2952648", "20623530"]}, {"Citation": "Kwon D., Cha B.G., Cho Y., Min J., Park E.B., Kang S.J., Kim J. Extra-Large Pore Mesoporous Silica Nanoparticles for Directing in Vivo M2 Macrophage Polarization by Delivering IL-4. Nano Lett. 2017;17:2747\u20132756. doi: 10.1021/acs.nanolett.6b04130.", "ArticleIdList": ["10.1021/acs.nanolett.6b04130", "28422506"]}, {"Citation": "Malvindi M.A., Brunetti V., Vecchio G., Galeone A., Cingolani R., Pompa P.P. SiO2 nanoparticles biocompatibility and their potential for gene delivery and silencing. Nanoscale. 2012;4:486\u2013495. doi: 10.1039/C1NR11269D.", "ArticleIdList": ["10.1039/C1NR11269D", "22095171"]}, {"Citation": "Abeer M.M., Rewatkar P., Qu Z., Talekar M., Kleitz F., Schmid R., Lind\u00e9n M., Kumeria T., Popat A. Silica nanoparticles: A promising platform for enhanced oral delivery of macromolecules. J. Control. Release. 2020;326:544\u2013555. doi: 10.1016/j.jconrel.2020.07.021.", "ArticleIdList": ["10.1016/j.jconrel.2020.07.021", "32687941"]}, {"Citation": "Diab R., Canilho N., Pavel I.A., Haffner F.B., Girardon M., Pasc A. Silica-based systems for oral delivery of drugs, macromolecules and cells. Adv. Colloid Interface Sci. 2017;249:346\u2013362. doi: 10.1016/j.cis.2017.04.005.", "ArticleIdList": ["10.1016/j.cis.2017.04.005", "28473052"]}, {"Citation": "Mohammadpour R., Cheney D.L., Grunberger J.W., Yazdimamaghani M., Jedrzkiewicz J., Isaacson K.J., Dobrovolskaia M.A., Ghandehari H. One-year chronic toxicity evaluation of single dose intravenously administered silica nanoparticles in mice and their Ex vivo human hemocompatibility. J. Control. Release. 2020;324:471\u2013481. doi: 10.1016/j.jconrel.2020.05.027.", "ArticleIdList": ["10.1016/j.jconrel.2020.05.027", "PMC7429347", "32464151"]}, {"Citation": "Fu C., Liu T., Li L., Liu H., Chen D., Tang F. The absorption, distribution, excretion and toxicity of mesoporous silica nanoparticles in mice following different exposure routes. Biomaterials. 2013;34:2565\u20132575. doi: 10.1016/j.biomaterials.2012.12.043.", "ArticleIdList": ["10.1016/j.biomaterials.2012.12.043", "23332175"]}, {"Citation": "Huang X., Li L., Liu T., Hao N., Liu H., Chen D., Tang F. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. ACS Nano. 2011;5:5390\u20135399. doi: 10.1021/nn200365a.", "ArticleIdList": ["10.1021/nn200365a", "21634407"]}, {"Citation": "Watermann A., Brieger J. Mesoporous Silica Nanoparticles as Drug Delivery Vehicles in Cancer. Nanomaterials. 2017;7:189. doi: 10.3390/nano7070189.", "ArticleIdList": ["10.3390/nano7070189", "PMC5535255", "28737672"]}, {"Citation": "Vallet-Reg\u00ed M., Colilla M., Izquierdo-Barba I., Manzano M. Mesoporous Silica Nanoparticles for Drug Delivery: Current Insights. Molecules. 2018;23:47. doi: 10.3390/molecules23010047.", "ArticleIdList": ["10.3390/molecules23010047", "PMC5943960", "29295564"]}, {"Citation": "Bukara K., Schueller L., Rosier J., Martens M.A., Daems T., Verheyden L., Eelen S., Van Speybroeck M., Libanati C., Martens J.A., et al. Ordered mesoporous silica to enhance the bioavailability of poorly water-soluble drugs: Proof of concept in man. Eur. J. Pharm. Biopharm. 2016;108:220\u2013225. doi: 10.1016/j.ejpb.2016.08.020.", "ArticleIdList": ["10.1016/j.ejpb.2016.08.020", "27648957"]}, {"Citation": "Cragg G.M., Newman D.J. Plants as a source of anti-cancer agents. J. Ethnopharmacol. 2005;100:72\u201379. doi: 10.1016/j.jep.2005.05.011.", "ArticleIdList": ["10.1016/j.jep.2005.05.011", "16009521"]}, {"Citation": "Harvey A.L. Natural products in drug discovery. Drug Discov. Today. 2008;13:894\u2013901. doi: 10.1016/j.drudis.2008.07.004.", "ArticleIdList": ["10.1016/j.drudis.2008.07.004", "18691670"]}, {"Citation": "Hostettmann K., Marston A. The Search for New Drugs from Higher Plants. Chim. Int. J. Chem. 2007;61:322\u2013326. doi: 10.2533/chimia.2007.322.", "ArticleIdList": ["10.2533/chimia.2007.322"]}, {"Citation": "Atanasov A.G., Waltenberger B., Pferschy-Wenzig E.M., Linder T., Wawrosch C., Uhrin P., Temml V., Wang L., Schwaiger S., Heiss E.H., et al. Discovery and resupply of pharmacologically active plant-derived natural products: A review. Biotechnol. Adv. 2015;33:1582\u20131614. doi: 10.1016/j.biotechadv.2015.08.001.", "ArticleIdList": ["10.1016/j.biotechadv.2015.08.001", "PMC4748402", "26281720"]}, {"Citation": "Ji H.-F., Li X.-J., Zhang H.-Y. Natural products and drug discovery. EMBO Rep. 2009;10:194\u2013200. doi: 10.1038/embor.2009.12.", "ArticleIdList": ["10.1038/embor.2009.12", "PMC2658564", "19229284"]}, {"Citation": "Watkins R., Wu L., Zhang C., Davis R.M., Xu B. Natural product-based nanomedicine: Recent advances and issues. Int. J. Nanomed. 2015;10:6055\u20136074. doi: 10.2147/ijn.s92162.", "ArticleIdList": ["10.2147/ijn.s92162", "PMC4592057", "26451111"]}, {"Citation": "Aljuffali I.A., Fang C.L., Chen C.H., Fang J.Y. Nanomedicine as a Strategy for Natural Compound Delivery to Prevent and Treat Cancers. Curr. Pharm. Des. 2016;22:4219\u20134231. doi: 10.2174/1381612822666160620072539.", "ArticleIdList": ["10.2174/1381612822666160620072539", "27323758"]}, {"Citation": "Fonseca-Santos B., Chorilli M. The uses of resveratrol for neurological diseases treatment and insights for nanotechnology based-drug delivery systems. Int. J. Pharm. 2020:119832. doi: 10.1016/j.ijpharm.2020.119832.", "ArticleIdList": ["10.1016/j.ijpharm.2020.119832", "32877730"]}, {"Citation": "AbouAitah K., Swiderska-Sroda A., Farghali A.A., Wojnarowicz J., Stefanek A., Gierlotka S., Opalinska A., Allayeh A.K., Ciach T., Lojkowski W. Folic acid-conjugated mesoporous silica particles as nanocarriers of natural prodrugs for cancer targeting and antioxidant action. Oncotarget. 2018;9:26466\u201326490. doi: 10.18632/oncotarget.25470.", "ArticleIdList": ["10.18632/oncotarget.25470", "PMC5995188", "29899871"]}, {"Citation": "AbouAitah K., Hassan H.A., Swiderska-Sroda A., Gohar L., Shaker O.G., Wojnarowicz J., Opalinska A., Smalc-Koziorowska J., Gierlotka S., Lojkowski W. Targeted Nano-Drug Delivery of Colchicine against Colon Cancer Cells by Means of Mesoporous Silica Nanoparticles. Cancers. 2020;12:144. doi: 10.3390/cancers12010144.", "ArticleIdList": ["10.3390/cancers12010144", "PMC7017376", "31936103"]}, {"Citation": "Shahein S.A., Aboul-Enein A.M., Higazy I.M., Abou-Elella F., Lojkowski W., Ahmed E.R., Mousa S.A., AbouAitah K. Targeted anticancer potential against glioma cells of thymoquinone delivered by mesoporous silica core-shell nanoformulations with pH-dependent release. Int. J. Nanomed. 2019;14:5503\u20135526. doi: 10.2147/IJN.S206899.", "ArticleIdList": ["10.2147/IJN.S206899", "PMC6650459", "31410001"]}, {"Citation": "Bisht S., Feldmann G., Soni S., Ravi R., Karikar C., Maitra A., Maitra A. Polymeric nanoparticle-encapsulated curcumin (\u201cnanocurcumin\u201d): A novel strategy for human cancer therapy. J. Nanobiotechnol. 2007;5:3. doi: 10.1186/1477-3155-5-3.", "ArticleIdList": ["10.1186/1477-3155-5-3", "PMC1868037", "17439648"]}, {"Citation": "Pool H., Quintanar D., Figueroa J.D.D., Marinho Mano C., Bechara J.E.H., God\u00ednez L.A., Mendoza S. Antioxidant Effects of Quercetin and Catechin Encapsulated into PLGA Nanoparticles. J. Nanomater. 2012;2012:145380. doi: 10.1155/2012/145380.", "ArticleIdList": ["10.1155/2012/145380"]}, {"Citation": "Fang Q., Sculley J., Zhou H.C.J., Zhu G. 5.01\u2014Porous Metal\u2013Organic Frameworks. In: Andrews D.L., Scholes G.D., Wiederrecht G.P., editors. Comprehensive Nanoscience and Technology. Academic Press; Amsterdam, The Netherlands: 2011. pp. 1\u201320."}, {"Citation": "Sing K.S.W. Reporting physisorption data for gas/solid systems. Pure Appl. Chem. 1982;54:2201\u20132218. doi: 10.1351/pac198254112201.", "ArticleIdList": ["10.1351/pac198254112201"]}, {"Citation": "Sing K.S.W. Reporting physisorption data for gas/solid systems with special reference to the determination of surface area and porosity (Recommendations 1984) Pure Appl. Chem. 1985;57:603\u2013619. doi: 10.1351/pac198557040603.", "ArticleIdList": ["10.1351/pac198557040603"]}, {"Citation": "Beck J.S., Vartuli J.C., Roth W.J., Leonowicz M.E., Kresge C.T., Schmitt K.D., Chu C.T.W., Olson D.H., Sheppard E.W., McCullen S.B., et al. A new family of mesoporous molecular sieves prepared with liquid crystal templates. J. Am. Chem. Soc. 1992;114:10834\u201310843. doi: 10.1021/ja00053a020.", "ArticleIdList": ["10.1021/ja00053a020"]}, {"Citation": "Inagaki S., Fukushima Y., Kuroda K. Synthesis of highly ordered mesoporous materials from a layered polysilicate. J. Chem. Soc. Chem. Commun. 1993:680\u2013682. doi: 10.1039/c39930000680.", "ArticleIdList": ["10.1039/c39930000680"]}, {"Citation": "Hoffmann F., Cornelius M., Morell J., Fr\u00f6ba M. Silica-Based Mesoporous Organic\u2013Inorganic Hybrid Materials. Angew. Chem. Int. Ed. 2006;45:3216\u20133251. doi: 10.1002/anie.200503075.", "ArticleIdList": ["10.1002/anie.200503075", "16676373"]}, {"Citation": "Ryoo R., Kim J.M., Ko C.H., Shin C.H. Disordered Molecular Sieve with Branched Mesoporous Channel Network. J. Phys. Chem. 1996;100:17718\u201317721. doi: 10.1021/jp9620835.", "ArticleIdList": ["10.1021/jp9620835"]}, {"Citation": "Zhou B., Li C.Y., Qi N., Jiang M., Wang B., Chen Z.Q. Pore structure of mesoporous silica (KIT-6) synthesized at different temperatures using positron as a nondestructive probe. Appl. Surf. Sci. 2018;450:31\u201337. doi: 10.1016/j.apsusc.2018.03.223.", "ArticleIdList": ["10.1016/j.apsusc.2018.03.223"]}, {"Citation": "Deka J.R., Lin Y.-H., Kao H.-M. Ordered cubic mesoporous silica KIT-5 functionalized with carboxylic acid groups for dye removal. RSC Adv. 2014;4:49061\u201349069. doi: 10.1039/C4RA08819K.", "ArticleIdList": ["10.1039/C4RA08819K"]}, {"Citation": "Zhao D., Feng J., Huo Q., Melosh N., Fredrickson G.H., Chmelka B.F., Stucky G.D. Triblock Copolymer Syntheses of Mesoporous Silica with Periodic 50 to 300 Angstrom Pores. Science. 1998;279:548. doi: 10.1126/science.279.5350.548.", "ArticleIdList": ["10.1126/science.279.5350.548", "9438845"]}, {"Citation": "Widenmeyer M., Anwander R. Pore Size Control of Highly Ordered Mesoporous Silica MCM-48. Chem. Mater. 2002;14:1827\u20131831. doi: 10.1021/cm011273b.", "ArticleIdList": ["10.1021/cm011273b"]}, {"Citation": "Lin L.-C., Thirumavalavan M., Wang Y.-T., Lee J.-F. Surface area and pore size tailoring of mesoporous silica materials by different hydrothermal treatments and adsorption of heavy metal ions. Colloids Surf. A Physicochem. Eng. Asp. 2010;369:223\u2013231. doi: 10.1016/j.colsurfa.2010.08.032.", "ArticleIdList": ["10.1016/j.colsurfa.2010.08.032"]}, {"Citation": "Polshettiwar V., Cha D., Zhang X., Basset J.M. High-Surface-Area Silica Nanospheres (KCC-1) with a Fibrous Morphology. Angew. Chem. Int. Ed. 2010;49:9652\u20139656. doi: 10.1002/anie.201003451.", "ArticleIdList": ["10.1002/anie.201003451", "20680958"]}, {"Citation": "Bayal N., Singh B., Singh R., Polshettiwar V. Size and Fiber Density Controlled Synthesis of Fibrous Nanosilica Spheres (KCC-1) Sci. Rep. 2016;6:24888. doi: 10.1038/srep24888.", "ArticleIdList": ["10.1038/srep24888", "PMC4846819", "27118152"]}, {"Citation": "Zhang S., Qian Y., Ahn W.-S. Catalytic dehydrogenation of formic acid over palladium nanoparticles immobilized on fibrous mesoporous silica KCC-1. Chin. J. Catal. 2019;40:1704\u20131712. doi: 10.1016/S1872-2067(19)63303-6.", "ArticleIdList": ["10.1016/S1872-2067(19)63303-6"]}, {"Citation": "Zarei F., Marjani A., Soltani R. Novel and green nanocomposite-based adsorbents from functionalised mesoporous KCC-1 and chitosan-oleic acid for adsorption of Pb(II) Eur. Polym. J. 2019;119:400\u2013409. doi: 10.1016/j.eurpolymj.2019.07.043.", "ArticleIdList": ["10.1016/j.eurpolymj.2019.07.043"]}, {"Citation": "Soleymani J., Hasanzadeh M., Somi M.H., Shadjou N., Jouyban A. Highly sensitive and specific cytosensing of HT 29 colorectal cancer cells using folic acid functionalized-KCC-1 nanoparticles. Biosens. Bioelectron. 2019;132:122\u2013131. doi: 10.1016/j.bios.2019.02.052.", "ArticleIdList": ["10.1016/j.bios.2019.02.052", "30870638"]}, {"Citation": "Abbasy L., Mohammadzadeh A., Hasanzadeh M., Ehsani M., Mokhtarzadeh A. Biosensing of prostate specific antigen (PSA) in human plasma samples using biomacromolecule encapsulation into KCC-1-npr-NH2: A new platform for prostate cancer detection. Int. J. Biol. Macromol. 2020;154:584\u2013595. doi: 10.1016/j.ijbiomac.2020.03.093.", "ArticleIdList": ["10.1016/j.ijbiomac.2020.03.093", "32173432"]}, {"Citation": "Ali Z., Tian L., Zhao P., Zhang B., Ali N., Khan M., Zhang Q. Immobilization of lipase on mesoporous silica nanoparticles with hierarchical fibrous pore. J. Mol. Catal. B Enzym. 2016;134:129\u2013135. doi: 10.1016/j.molcatb.2016.10.011.", "ArticleIdList": ["10.1016/j.molcatb.2016.10.011"]}, {"Citation": "Follmann H.D.M., Oliveira O.N., Martins A.C., Lazarin-Bid\u00f3ia D., Nakamura C.V., Rubira A.F., Silva R., Asefa T. Nanofibrous silica microparticles/polymer hybrid aerogels for sustained delivery of poorly water-soluble camptothecin. J. Colloid Interface Sci. 2020;567:92\u2013102. doi: 10.1016/j.jcis.2020.01.110.", "ArticleIdList": ["10.1016/j.jcis.2020.01.110", "32036118"]}, {"Citation": "Peng H., Wang D., Xu L., Wu P. One-pot synthesis of primary amides on bifunctional Rh(OH)x/TS-1@KCC-1 catalysts. Chin. J. Catal. 2013;34:2057\u20132065. doi: 10.1016/S1872-2067(12)60670-6.", "ArticleIdList": ["10.1016/S1872-2067(12)60670-6"]}, {"Citation": "AbouAitah K.E.A., Farghali A.A., Swiderska-Sroda A., Lojkowski W., Razin A.M. Mesoporous silica materials in drug delivery system: pH/glutathione-responsive release of poorly water-soluble pro-drug quercetin from two and three-dimensional pore-structure nanoparticles. J. Nanomed. Nanotechnol. 2016:7. doi: 10.4172/2157-7439.1000360.", "ArticleIdList": ["10.4172/2157-7439.1000360"]}, {"Citation": "AbouAitah K.E.A., Farghali A.A., Swiderska-Sroda A., Lojkowski W., Razin A.M. pH-controlled release system for curcumin based on functionalized dendritic mesoporous silica nanoparticles. J. Nanomed. Nanotechnol. 2016;7:1\u201311."}, {"Citation": "Lin J., Peng C., Ravi S., Siddiki A.K.M.N.A., Zheng J., Balkus K.J. Biphenyl Wrinkled Mesoporous Silica Nanoparticles for pH-Responsive Doxorubicin Drug Delivery. Materials. 2020;13:1998. doi: 10.3390/ma13081998.", "ArticleIdList": ["10.3390/ma13081998", "PMC7215304", "32344722"]}, {"Citation": "Moon D.-S., Lee J.-K. Tunable Synthesis of Hierarchical Mesoporous Silica Nanoparticles with Radial Wrinkle Structure. Langmuir. 2012;28:12341\u201312347. doi: 10.1021/la302145j.", "ArticleIdList": ["10.1021/la302145j", "22861383"]}, {"Citation": "Wang R., Habib E., Zhu X.X. Synthesis of wrinkled mesoporous silica and its reinforcing effect for dental resin composites. Dent. Mater. 2017;33:1139\u20131148. doi: 10.1016/j.dental.2017.07.012.", "ArticleIdList": ["10.1016/j.dental.2017.07.012", "28797746"]}, {"Citation": "Maity A., Polshettiwar V. Dendritic Fibrous Nanosilica for Catalysis, Energy Harvesting, Carbon Dioxide Mitigation, Drug Delivery, and Sensing. ChemSusChem. 2017;10:3866\u20133913. doi: 10.1002/cssc.201701076.", "ArticleIdList": ["10.1002/cssc.201701076", "PMC5698778", "28834600"]}, {"Citation": "Szcz\u0119\u015bniak B., Choma J., Jaroniec M. Major advances in the development of ordered mesoporous materials. Chem. Commun. 2020;56:7836\u20137848. doi: 10.1039/D0CC02840A.", "ArticleIdList": ["10.1039/D0CC02840A", "32520012"]}, {"Citation": "Xu C., Lei C., Yu C. Mesoporous Silica Nanoparticles for Protein Protection and Delivery. Front. Chem. 2019;7:290. doi: 10.3389/fchem.2019.00290.", "ArticleIdList": ["10.3389/fchem.2019.00290", "PMC6504683", "31119124"]}, {"Citation": "Douroumis D., Onyesom I., Maniruzzaman M., Mitchell J. Mesoporous silica nanoparticles in nanotechnology. Crit. Rev. Biotechnol. 2013;33:229\u2013245. doi: 10.3109/07388551.2012.685860.", "ArticleIdList": ["10.3109/07388551.2012.685860", "22724458"]}, {"Citation": "Wu S.-H., Mou C.-Y., Lin H.-P. Synthesis of mesoporous silica nanoparticles. Chem. Soc. Rev. 2013;42:3862\u20133875. doi: 10.1039/c3cs35405a.", "ArticleIdList": ["10.1039/c3cs35405a", "23403864"]}, {"Citation": "Farjadian F., Roointan A., Mohammadi-Samani S., Hosseini M. Mesoporous silica nanoparticles: Synthesis, pharmaceutical applications, biodistribution, and biosafety assessment. Chem. Eng. J. 2019;359:684\u2013705. doi: 10.1016/j.cej.2018.11.156.", "ArticleIdList": ["10.1016/j.cej.2018.11.156"]}, {"Citation": "Castillo R.R., Lozano D., Gonz\u00e1lez B., Manzano M., Izquierdo-Barba I., Vallet-Reg\u00ed M. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery: An update. Expert Opin. Drug Deliv. 2019;16:415\u2013439. doi: 10.1080/17425247.2019.1598375.", "ArticleIdList": ["10.1080/17425247.2019.1598375", "PMC6667337", "30897978"]}, {"Citation": "Paris J.L., Vallet-Reg\u00ed M. Mesoporous Silica Nanoparticles for Co-Delivery of Drugs and Nucleic Acids in Oncology: A Review. Pharmaceutics. 2020;12:526. doi: 10.3390/pharmaceutics12060526.", "ArticleIdList": ["10.3390/pharmaceutics12060526", "PMC7356816", "32521800"]}, {"Citation": "Aquib M., Farooq M.A., Banerjee P., Akhtar F., Filli M.S., Boakye-Yiadom K.O., Kesse S., Raza F., Maviah M.B.J., Mavlyanova R., et al. Targeted and stimuli\u2013responsive mesoporous silica nanoparticles for drug delivery and theranostic use. J. Biomed. Mater. Res. Part A. 2019;107:2643\u20132666. doi: 10.1002/jbm.a.36770.", "ArticleIdList": ["10.1002/jbm.a.36770", "31390141"]}, {"Citation": "Hadipour Moghaddam S.P., Mohammadpour R., Ghandehari H. In vitro and in vivo evaluation of degradation, toxicity, biodistribution, and clearance of silica nanoparticles as a function of size, porosity, density, and composition. J. Control. Release. 2019;311\u2013312:1\u201315. doi: 10.1016/j.jconrel.2019.08.028.", "ArticleIdList": ["10.1016/j.jconrel.2019.08.028", "PMC6874921", "31465825"]}, {"Citation": "Li Z., Zhang Y., Feng N. Mesoporous silica nanoparticles: Synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery. Expert Opin. Drug Deliv. 2019;16:219\u2013237. doi: 10.1080/17425247.2019.1575806.", "ArticleIdList": ["10.1080/17425247.2019.1575806", "30686075"]}, {"Citation": "Nieto A., Colilla M., Balas F., Vallet-Reg\u00ed M. Surface Electrochemistry of Mesoporous Silicas as a Key Factor in the Design of Tailored Delivery Devices. Langmuir. 2010;26:5038\u20135049. doi: 10.1021/la904820k.", "ArticleIdList": ["10.1021/la904820k", "20222698"]}, {"Citation": "Vallet-Reg\u00ed M., Balas F., Arcos D. Mesoporous Materials for Drug Delivery. Angew. Chem. Int. Ed. 2007;46:7548\u20137558. doi: 10.1002/anie.200604488.", "ArticleIdList": ["10.1002/anie.200604488", "17854012"]}, {"Citation": "Rahikkala A., Rosenholm J.M., Santos H.A. Chapter 16\u2014Biofunctionalized Mesoporous Silica Nanomaterials for Targeted Drug Delivery. In: Sarmento B., das Neves J., editors. Biomedical Applications of Functionalized Nanomaterials. Elsevier; Amsterdam, The Netherlands: 2018. pp. 489\u2013520."}, {"Citation": "Stein A., Melde B.J., Schroden R.C. Hybrid Inorganic\u2013Organic Mesoporous Silicates\u2014Nanoscopic Reactors Coming of Age. Adv. Mater. 2000;12:1403\u20131419. doi: 10.1002/1521-4095(200010)12:19<1403::AID-ADMA1403>3.0.CO;2-X.", "ArticleIdList": ["10.1002/1521-4095(200010)12:19<1403::AID-ADMA1403>3.0.CO;2-X"]}, {"Citation": "Tarn D., Ashley C.E., Xue M., Carnes E.C., Zink J.I., Brinker C.J. Mesoporous Silica Nanoparticle Nanocarriers: Biofunctionality and Biocompatibility. Acc. Chem. Res. 2013;46:792\u2013801. doi: 10.1021/ar3000986.", "ArticleIdList": ["10.1021/ar3000986", "PMC3686852", "23387478"]}, {"Citation": "Huh S., Wiench J.W., Yoo J.-C., Pruski M., Lin V.S.Y. Organic Functionalization and Morphology Control of Mesoporous Silicas via a Co-Condensation Synthesis Method. Chem. Mater. 2003;15:4247\u20134256. doi: 10.1021/cm0210041.", "ArticleIdList": ["10.1021/cm0210041"]}, {"Citation": "Lu J., Liong M., Zink J.I., Tamanoi F. Mesoporous Silica Nanoparticles as a Delivery System for Hydrophobic Anticancer Drugs. Small. 2007;3:1341\u20131346. doi: 10.1002/smll.200700005.", "ArticleIdList": ["10.1002/smll.200700005", "17566138"]}, {"Citation": "Sayari A., Hamoudi S. Periodic Mesoporous Silica-Based Organic\u2212Inorganic Nanocomposite Materials. Chem. Mater. 2001;13:3151\u20133168. doi: 10.1021/cm011039l.", "ArticleIdList": ["10.1021/cm011039l"]}, {"Citation": "Wu S.-H., Hung Y., Mou C.-Y. Mesoporous silica nanoparticles as nanocarriers. Chem. Commun. 2011;47:9972\u20139985. doi: 10.1039/c1cc11760b.", "ArticleIdList": ["10.1039/c1cc11760b", "21716992"]}, {"Citation": "Manzanares D., Ce\u00f1a V. Endocytosis: The Nanoparticle and Submicron Nanocompounds Gateway into the Cell. Pharmaceutics. 2020;12:371. doi: 10.3390/pharmaceutics12040371.", "ArticleIdList": ["10.3390/pharmaceutics12040371", "PMC7238190", "32316537"]}, {"Citation": "Kou L., Sun J., Zhai Y., He Z. The endocytosis and intracellular fate of nanomedicines: Implication for rational design. Asian J. Pharm. Sci. 2013;8:1\u201310. doi: 10.1016/j.ajps.2013.07.001.", "ArticleIdList": ["10.1016/j.ajps.2013.07.001"]}, {"Citation": "Borb\u00e1s E., Sink\u00f3 B., Tsinman O., Tsinman K., Kiserdei \u00c9., D\u00e9muth B., Balogh A., Bod\u00e1k B., Domokos A., Darg\u00f3 G., et al. Investigation and Mathematical Description of the Real Driving Force of Passive Transport of Drug Molecules from Supersaturated Solutions. Mol. Pharm. 2016;13:3816\u20133826. doi: 10.1021/acs.molpharmaceut.6b00613.", "ArticleIdList": ["10.1021/acs.molpharmaceut.6b00613", "27611057"]}, {"Citation": "Doherty G.J., McMahon H.T. Mechanisms of Endocytosis. Annu. Rev. Biochem. 2009;78:857\u2013902. doi: 10.1146/annurev.biochem.78.081307.110540.", "ArticleIdList": ["10.1146/annurev.biochem.78.081307.110540", "19317650"]}, {"Citation": "Rewatkar P., Kumeria T., Popat A. Chapter 5\u2014Size, shape and surface charge considerations of orally delivered nanomedicines. In: Martins J.P., Santos H.A., editors. Nanotechnology for Oral Drug Delivery. Academic Press; Cambridge, MA, USA: 2020. pp. 143\u2013176."}, {"Citation": "He C., Hu Y., Yin L., Tang C., Yin C. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials. 2010;31:3657\u20133666. doi: 10.1016/j.biomaterials.2010.01.065.", "ArticleIdList": ["10.1016/j.biomaterials.2010.01.065", "20138662"]}, {"Citation": "McMahon H.T., Boucrot E. Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat. Rev. Mol. Cell Biol. 2011;12:517\u2013533. doi: 10.1038/nrm3151.", "ArticleIdList": ["10.1038/nrm3151", "21779028"]}, {"Citation": "Sahay G., Alakhova D.Y., Kabanov A.V. Endocytosis of nanomedicines. J. Control. Release. 2010;145:182\u2013195. doi: 10.1016/j.jconrel.2010.01.036.", "ArticleIdList": ["10.1016/j.jconrel.2010.01.036", "PMC2902597", "20226220"]}, {"Citation": "Foroozandeh P., Aziz A.A. Insight into Cellular Uptake and Intracellular Trafficking of Nanoparticles. Nanoscale Res. Lett. 2018;13:339. doi: 10.1186/s11671-018-2728-6.", "ArticleIdList": ["10.1186/s11671-018-2728-6", "PMC6202307", "30361809"]}, {"Citation": "Gustafson H.H., Holt-Casper D., Grainger D.W., Ghandehari H. Nanoparticle Uptake: The Phagocyte Problem. Nano Today. 2015;10:487\u2013510. doi: 10.1016/j.nantod.2015.06.006.", "ArticleIdList": ["10.1016/j.nantod.2015.06.006", "PMC4666556", "26640510"]}, {"Citation": "Lu F., Wu S.-H., Hung Y., Mou C.-Y. Size Effect on Cell Uptake in Well-Suspended, Uniform Mesoporous Silica Nanoparticles. Small. 2009;5:1408\u20131413. doi: 10.1002/smll.200900005.", "ArticleIdList": ["10.1002/smll.200900005", "19296554"]}, {"Citation": "Gratton S.E.A., Ropp P.A., Pohlhaus P.D., Luft J.C., Madden V.J., Napier M.E., DeSimone J.M. The effect of particle design on cellular internalization pathways. Proc. Natl. Acad. Sci. USA. 2008;105:11613\u201311618. doi: 10.1073/pnas.0801763105.", "ArticleIdList": ["10.1073/pnas.0801763105", "PMC2575324", "18697944"]}, {"Citation": "Min Y., Akbulut M., Kristiansen K., Golan Y., Israelachvili J. Nanoscience and Technology: A Collection of Reviews from Nature Journals. World Scientific; Singapore: 2010. The role of interparticle and external forces in nanoparticle assembly; pp. 38\u201349."}, {"Citation": "Wei P., Zhang L., Lu Y., Man N., Wen L. C60 (Nd) nanoparticles enhance chemotherapeutic susceptibility of cancer cells by modulation of autophagy. Nanotechnology. 2010;21:495101. doi: 10.1088/0957-4484/21/49/495101.", "ArticleIdList": ["10.1088/0957-4484/21/49/495101", "21071824"]}, {"Citation": "Song L., Wengang L., Niveen M.K. Stimuli responsive nanomaterials for controlled release applications. Nanotechnol. Rev. 2012;1:493\u2013513. doi: 10.1515/ntrev-2012-0033.", "ArticleIdList": ["10.1515/ntrev-2012-0033"]}, {"Citation": "Behzadi S., Serpooshan V., Tao W., Hamaly M.A., Alkawareek M.Y., Dreaden E.C., Brown D., Alkilany A.M., Farokhzad O.C., Mahmoudi M. Cellular uptake of nanoparticles: Journey inside the cell. Chem. Soc. Rev. 2017;46:4218\u20134244. doi: 10.1039/C6CS00636A.", "ArticleIdList": ["10.1039/C6CS00636A", "PMC5593313", "28585944"]}, {"Citation": "Biswas A.K., Islam M.R., Choudhury Z.S., Mostafa A., Kadir M.F. Nanotechnology based approaches in cancer therapeutics. Adv. Nat. Sci. Nanosci. Nanotechnol. 2014;5:043001. doi: 10.1088/2043-6262/5/4/043001.", "ArticleIdList": ["10.1088/2043-6262/5/4/043001"]}, {"Citation": "Neuberger T., Sch\u00f6pf B., Hofmann H., Hofmann M., von Rechenberg B. Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system. J. Magn. Magn. Mater. 2005;293:483\u2013496. doi: 10.1016/j.jmmm.2005.01.064.", "ArticleIdList": ["10.1016/j.jmmm.2005.01.064"]}, {"Citation": "Maruyama K. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. Adv. Drug Deliv. Rev. 2011;63:161\u2013169. doi: 10.1016/j.addr.2010.09.003.", "ArticleIdList": ["10.1016/j.addr.2010.09.003", "20869415"]}, {"Citation": "Maeda H., Wu J., Sawa T., Matsumura Y., Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J. Control. Release. 2000;65:271\u2013284. doi: 10.1016/S0168-3659(99)00248-5.", "ArticleIdList": ["10.1016/S0168-3659(99)00248-5", "10699287"]}, {"Citation": "Haddick L., Zhang W., Reinhard S., M\u00f6ller K., Engelke H., Wagner E., Bein T. Particle-Size-Dependent Delivery of Antitumoral miRNA Using Targeted Mesoporous Silica Nanoparticles. Pharmaceutics. 2020;12:505. doi: 10.3390/pharmaceutics12060505.", "ArticleIdList": ["10.3390/pharmaceutics12060505", "PMC7355705", "32498278"]}, {"Citation": "Yang Y., Karmakar S., Zhang J., Yu M., Mitter N., Yu C. Synthesis of SBA-15 rods with small sizes for enhanced cellular uptake. J. Mater. Chem. B. 2014;2:4929\u20134934. doi: 10.1039/C4TB00595C.", "ArticleIdList": ["10.1039/C4TB00595C", "32261785"]}, {"Citation": "Zhu M., Nie G., Meng H., Xia T., Nel A., Zhao Y. Physicochemical Properties Determine Nanomaterial Cellular Uptake, Transport, and Fate. Acc. Chem. Res. 2013;46:622\u2013631. doi: 10.1021/ar300031y.", "ArticleIdList": ["10.1021/ar300031y", "PMC4414238", "22891796"]}, {"Citation": "Panariti A., Miserocchi G., Rivolta I. The effect of nanoparticle uptake on cellular behavior: Disrupting or enabling functions? Nanotechnol. Sci. Appl. 2012;5:87\u2013100. doi: 10.2147/NSA.S25515.", "ArticleIdList": ["10.2147/NSA.S25515", "PMC3781724", "24198499"]}, {"Citation": "Adjei I.M., Sharma B., Labhasetwar V. Nanoparticles: Cellular uptake and cytotoxicity. Adv. Exp. Med. Biol. 2014;811:73\u201391. doi: 10.1007/978-94-017-8739-0_5.", "ArticleIdList": ["10.1007/978-94-017-8739-0_5", "24683028"]}, {"Citation": "Marano F., Hussain S., Rodrigues-Lima F., Baeza-Squiban A., Boland S. Nanoparticles: Molecular targets and cell signalling. Arch. Toxicol. 2011;85:733\u2013741. doi: 10.1007/s00204-010-0546-4.", "ArticleIdList": ["10.1007/s00204-010-0546-4", "20502881"]}, {"Citation": "Fr\u00f6hlich E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int. J. Nanomed. 2012;7:5577\u20135591. doi: 10.2147/IJN.S36111.", "ArticleIdList": ["10.2147/IJN.S36111", "PMC3493258", "23144561"]}, {"Citation": "Allen T.M., Austin G.A., Chonn A., Lin L., Lee K.C. Uptake of liposomes by cultured mouse bone marrow macrophages: Influence of liposome composition and size. Biochim. Biophys. Acta (BBA) Biomembr. 1991;1061:56\u201364. doi: 10.1016/0005-2736(91)90268-D.", "ArticleIdList": ["10.1016/0005-2736(91)90268-D", "1995057"]}, {"Citation": "Arvizo R.R., Miranda O.R., Thompson M.A., Pabelick C.M., Bhattacharya R., Robertson J.D., Rotello V.M., Prakash Y.S., Mukherjee P. Effect of Nanoparticle Surface Charge at the Plasma Membrane and Beyond. Nano Lett. 2010;10:2543\u20132548. doi: 10.1021/nl101140t.", "ArticleIdList": ["10.1021/nl101140t", "PMC2925219", "20533851"]}, {"Citation": "Wang B., Zhang L., Bae S.C., Granick S. Nanoparticle-induced surface reconstruction of phospholipid membranes. Proc. Natl. Acad. Sci. USA. 2008;105:18171\u201318175. doi: 10.1073/pnas.0807296105.", "ArticleIdList": ["10.1073/pnas.0807296105", "PMC2587577", "19011086"]}, {"Citation": "Dausend J., Musyanovych A., Dass M., Walther P., Schrezenmeier H., Landfester K., Mail\u00e4nder V. Uptake Mechanism of Oppositely Charged Fluorescent Nanoparticles in HeLa Cells. Macromol. Biosci. 2008;8:1135\u20131143. doi: 10.1002/mabi.200800123.", "ArticleIdList": ["10.1002/mabi.200800123", "18698581"]}, {"Citation": "Jambhrunkar S., Qu Z., Popat A., Yang J., Noonan O., Acauan L., Ahmad Nor Y., Yu C., Karmakar S. Effect of Surface Functionality of Silica Nanoparticles on Cellular Uptake and Cytotoxicity. Mol. Pharm. 2014;11:3642\u20133655. doi: 10.1021/mp500385n.", "ArticleIdList": ["10.1021/mp500385n", "25166282"]}, {"Citation": "Baghirov H., Karaman D., Viitala T., Duchanoy A., Lou Y.-R., Mamaeva V., Pryazhnikov E., Khiroug L., de Lange Davies C., Sahlgren C., et al. Feasibility Study of the Permeability and Uptake of Mesoporous Silica Nanoparticles across the Blood-Brain Barrier. PLoS ONE. 2016;11:e0160705. doi: 10.1371/journal.pone.0160705.", "ArticleIdList": ["10.1371/journal.pone.0160705", "PMC4993362", "27547955"]}, {"Citation": "Trewyn B.G., Nieweg J.A., Zhao Y., Lin V.S.Y. Biocompatible mesoporous silica nanoparticles with different morphologies for animal cell membrane penetration. Chem. Eng. J. 2008;137:23\u201329. doi: 10.1016/j.cej.2007.09.045.", "ArticleIdList": ["10.1016/j.cej.2007.09.045"]}, {"Citation": "Huang X., Teng X., Chen D., Tang F., He J. The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. Biomaterials. 2010;31:438\u2013448. doi: 10.1016/j.biomaterials.2009.09.060.", "ArticleIdList": ["10.1016/j.biomaterials.2009.09.060", "19800115"]}, {"Citation": "Dias D.R., Moreira A.F., Correia I.J. The effect of the shape of gold core\u2013mesoporous silica shell nanoparticles on the cellular behavior and tumor spheroid penetration. J. Mater. Chem. B. 2016;4:7630\u20137640. doi: 10.1039/C6TB02668K.", "ArticleIdList": ["10.1039/C6TB02668K", "32263819"]}, {"Citation": "Pada A.-K., Desai D., Sun K., Prakirth Govardhanam N., T\u00f6rnquist K., Zhang J., Rosenholm J.M. Comparison of Polydopamine-Coated Mesoporous Silica Nanorods and Spheres for the Delivery of Hydrophilic and Hydrophobic Anticancer Drugs. Int. J. Mol. Sci. 2019;20:3408. doi: 10.3390/ijms20143408.", "ArticleIdList": ["10.3390/ijms20143408", "PMC6679059", "31336697"]}, {"Citation": "Hao N., Li L., Tang F. Shape matters when engineering mesoporous silica-based nanomedicines. Biomater. Sci. 2016;4:575\u2013591. doi: 10.1039/C5BM00589B.", "ArticleIdList": ["10.1039/C5BM00589B", "26818852"]}, {"Citation": "Tang F., Li L., Chen D. Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery. Adv. Mater. 2012;24:1504\u20131534. doi: 10.1002/adma.201104763.", "ArticleIdList": ["10.1002/adma.201104763", "22378538"]}, {"Citation": "Niculescu V.-C. Mesoporous Silica Nanoparticles for Bio-Applications. Front. Mater. 2020:7. doi: 10.3389/fmats.2020.00036.", "ArticleIdList": ["10.3389/fmats.2020.00036"]}, {"Citation": "Hosseinpour S., Walsh L.J., Xu C. Biomedical application of mesoporous silica nanoparticles as delivery systems: A biological safety perspective. J. Mater. Chem. B. 2020;8:9863\u20139876. doi: 10.1039/D0TB01868F.", "ArticleIdList": ["10.1039/D0TB01868F", "33047764"]}, {"Citation": "Trewyn B.G., Giri S., Slowing I.I., Lin V.S.Y. Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems. Chem. Commun. 2007:3236\u20133245. doi: 10.1039/b701744h.", "ArticleIdList": ["10.1039/b701744h", "17668088"]}, {"Citation": "Manzano M., Colilla M., Vallet-Reg\u00ed M. Drug delivery from ordered mesoporous matrices. Expert Opin Drug Deliv. 2009;6:1383\u20131400. doi: 10.1517/17425240903304024.", "ArticleIdList": ["10.1517/17425240903304024", "19941412"]}, {"Citation": "Vivero-Escoto J.L., Slowing I.I., Trewyn B.G., Lin V.S.Y. Mesoporous Silica Nanoparticles for Intracellular Controlled Drug Delivery. Small. 2010;6:1952\u20131967. doi: 10.1002/smll.200901789.", "ArticleIdList": ["10.1002/smll.200901789", "20690133"]}, {"Citation": "Asefa T., Tao Z. Biocompatibility of Mesoporous Silica Nanoparticles. Chem. Res. Toxicol. 2012;25:2265\u20132284. doi: 10.1021/tx300166u.", "ArticleIdList": ["10.1021/tx300166u", "22823891"]}, {"Citation": "Park J.-H., Gu L., von Maltzahn G., Ruoslahti E., Bhatia S.N., Sailor M.J. Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat. Mater. 2009;8:331\u2013336. doi: 10.1038/nmat2398.", "ArticleIdList": ["10.1038/nmat2398", "PMC3058936", "19234444"]}, {"Citation": "Hudson S.P., Padera R.F., Langer R., Kohane D.S. The biocompatibility of mesoporous silicates. Biomaterials. 2008;29:4045\u20134055. doi: 10.1016/j.biomaterials.2008.07.007.", "ArticleIdList": ["10.1016/j.biomaterials.2008.07.007", "PMC2602836", "18675454"]}, {"Citation": "Yildirim A., Ozgur E., Bayindir M. Impact of mesoporous silica nanoparticle surface functionality on hemolytic activity, thrombogenicity and non-specific protein adsorption. J. Mater. Chem. B. 2013;1:1909\u20131920. doi: 10.1039/c3tb20139b.", "ArticleIdList": ["10.1039/c3tb20139b", "32260904"]}, {"Citation": "Garrido-Cano I., Candela-Noguera V., Herrera G., Cejalvo J.M., Lluch A., Marcos M.D., Sancenon F., Eroles P., Mart\u00ednez-M\u00e1\u00f1ez R. Biocompatibility and internalization assessment of bare and functionalised mesoporous silica nanoparticles. Microporous Mesoporous Mater. 2021:310. doi: 10.1016/j.micromeso.2020.110593.", "ArticleIdList": ["10.1016/j.micromeso.2020.110593"]}, {"Citation": "He Q., Zhang Z., Gao F., Li Y., Shi J. In vivo Biodistribution and Urinary Excretion of Mesoporous Silica Nanoparticles: Effects of Particle Size and PEGylation. Small. 2011;7:271\u2013280. doi: 10.1002/smll.201001459.", "ArticleIdList": ["10.1002/smll.201001459", "21213393"]}, {"Citation": "Yu T., Hubbard D., Ray A., Ghandehari H. In vivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface characteristics. J. Control. Release. 2012;163:46\u201354. doi: 10.1016/j.jconrel.2012.05.046.", "ArticleIdList": ["10.1016/j.jconrel.2012.05.046", "PMC3476833", "22684119"]}, {"Citation": "Li L., Liu T., Fu C., Tan L., Meng X., Liu H. Biodistribution, excretion, and toxicity of mesoporous silica nanoparticles after oral administration depend on their shape. Nanomed. Nanotechnol. Biol. Med. 2015;11:1915\u20131924. doi: 10.1016/j.nano.2015.07.004.", "ArticleIdList": ["10.1016/j.nano.2015.07.004", "26238077"]}, {"Citation": "Zhao Y., Wang Y., Ran F., Cui Y., Liu C., Zhao Q., Gao Y., Wang D., Wang S. A comparison between sphere and rod nanoparticles regarding their in vivo biological behavior and pharmacokinetics. Sci. Rep. 2017;7:4131. doi: 10.1038/s41598-017-03834-2.", "ArticleIdList": ["10.1038/s41598-017-03834-2", "PMC5482848", "28646143"]}, {"Citation": "Jan\u00dfen H.C., Warwas D.P., Dahlhaus D., Mei\u00dfner J., Taptimthong P., Kietzmann M., Behrens P., Reifenrath J., Angrisani N. In vitro and in vivo accumulation of magnetic nanoporous silica nanoparticles on implant materials with different magnetic properties. J. Nanobiotechnol. 2018;16:96. doi: 10.1186/s12951-018-0422-6.", "ArticleIdList": ["10.1186/s12951-018-0422-6", "PMC6258308", "30482189"]}, {"Citation": "Li H., Wu X., Yang B., Li J., Xu L., Liu H., Li S., Xu J., Yang M., Wei M. Evaluation of biomimetically synthesized mesoporous silica nanoparticles as drug carriers: Structure, wettability, degradation, biocompatibility and brain distribution. Mater. Sci. Eng. C. 2019;94:453\u2013464. doi: 10.1016/j.msec.2018.09.053.", "ArticleIdList": ["10.1016/j.msec.2018.09.053", "30423730"]}, {"Citation": "Cho M., Cho W.-S., Choi M., Kim S.J., Han B.S., Kim S.H., Kim H.O., Sheen Y.Y., Jeong J. The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. Toxicol. Lett. 2009;189:177\u2013183. doi: 10.1016/j.toxlet.2009.04.017.", "ArticleIdList": ["10.1016/j.toxlet.2009.04.017", "19397964"]}, {"Citation": "Hornung V., Bauernfeind F., Halle A., Samstad E.O., Kono H., Rock K.L., Fitzgerald K.A., Latz E. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 2008;9:847\u2013856. doi: 10.1038/ni.1631.", "ArticleIdList": ["10.1038/ni.1631", "PMC2834784", "18604214"]}, {"Citation": "Jones L.H.P., Handreck K.A. Silica In Soils, Plants, and Animals. In: Norman A.G., editor. Advances in Agronomy. Volume 19. Academic Press; Cambridge, MA, USA: 1967. pp. 107\u2013149."}, {"Citation": "Rosenholm J.M., Mamaeva V., Sahlgren C., Lind\u00e9n M. Nanoparticles in targeted cancer therapy: Mesoporous silica nanoparticles entering preclinical development stage. Nanomedicine. 2012;7:111\u2013120. doi: 10.2217/nnm.11.166.", "ArticleIdList": ["10.2217/nnm.11.166", "22191780"]}, {"Citation": "Martin K.R. Silicon: The Health Benefits of a Metalloid. In: Sigel A., Sigel H., Sigel R.K.O., editors. Interrelations between Essential Metal Ions and Human Diseases. Springer; Dordrecht, The Netherlands: 2013. pp. 451\u2013473.", "ArticleIdList": ["24470100"]}, {"Citation": "Ehrlich H., Demadis K.D., Pokrovsky O.S., Koutsoukos P.G. Modern Views on Desilicification: Biosilica and Abiotic Silica Dissolution in Natural and Artificial Environments. Chem. Rev. 2010;110:4656\u20134689. doi: 10.1021/cr900334y.", "ArticleIdList": ["10.1021/cr900334y", "20441201"]}, {"Citation": "Martin K.R. The chemistry of silica and its potential health benefits. J. Nutr. Health Aging. 2007;11:94\u201397.", "ArticleIdList": ["17435951"]}, {"Citation": "Croissant J.G., Fatieiev Y., Khashab N.M. Degradability and Clearance of Silicon, Organosilica, Silsesquioxane, Silica Mixed Oxide, and Mesoporous Silica Nanoparticles. Adv. Mater. 2017;29:1604634. doi: 10.1002/adma.201604634.", "ArticleIdList": ["10.1002/adma.201604634", "28084658"]}, {"Citation": "Carlisle E.M. Silicon: A Possible Factor in Bone Calcification. Science. 1970;167:279. doi: 10.1126/science.167.3916.279.", "ArticleIdList": ["10.1126/science.167.3916.279", "5410261"]}, {"Citation": "Jugdaohsingh R. Silicon and bone health. J. Nutr Health Aging. 2007;11:99\u2013110.", "ArticleIdList": ["PMC2658806", "17435952"]}, {"Citation": "Benezra M., Penate-Medina O., Zanzonico P.B., Schaer D., Ow H., Burns A., DeStanchina E., Longo V., Herz E., Iyer S., et al. Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. J. Clin. Investig. 2011;121:2768\u20132780. doi: 10.1172/JCI45600.", "ArticleIdList": ["10.1172/JCI45600", "PMC3223837", "21670497"]}, {"Citation": "Quan G., Pan X., Wang Z., Wu Q., Li G., Dian L., Chen B., Wu C. Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery. J. Nanobiotechnol. 2015;13:7. doi: 10.1186/s12951-015-0068-6.", "ArticleIdList": ["10.1186/s12951-015-0068-6", "PMC4333889", "25643602"]}, {"Citation": "Napierska D., Thomassen L.C.J., Lison D., Martens J.A., Hoet P.H. The nanosilica hazard: Another variable entity. Part. Fibre Toxicol. 2010;7:39. doi: 10.1186/1743-8977-7-39.", "ArticleIdList": ["10.1186/1743-8977-7-39", "PMC3014868", "21126379"]}, {"Citation": "Di Pasqua A.J., Sharma K.K., Shi Y.-L., Toms B.B., Ouellette W., Dabrowiak J.C., Asefa T. Cytotoxicity of mesoporous silica nanomaterials. J. Inorg. Biochem. 2008;102:1416\u20131423. doi: 10.1016/j.jinorgbio.2007.12.028.", "ArticleIdList": ["10.1016/j.jinorgbio.2007.12.028", "18279965"]}, {"Citation": "Lee S., Yun H.-S., Kim S.-H. The comparative effects of mesoporous silica nanoparticles and colloidal silica on inflammation and apoptosis. Biomaterials. 2011;32:9434\u20139443. doi: 10.1016/j.biomaterials.2011.08.042.", "ArticleIdList": ["10.1016/j.biomaterials.2011.08.042", "21889200"]}, {"Citation": "Li Y., Sun L., Jin M., Du Z., Liu X., Guo C., Li Y., Huang P., Sun Z. Size-dependent cytotoxicity of amorphous silica nanoparticles in human hepatoma HepG2 cells. Toxicol. In Vitro. 2011;25:1343\u20131352. doi: 10.1016/j.tiv.2011.05.003.", "ArticleIdList": ["10.1016/j.tiv.2011.05.003", "21575712"]}, {"Citation": "Liu T., Li L., Teng X., Huang X., Liu H., Chen D., Ren J., He J., Tang F. Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice. Biomaterials. 2011;32:1657\u20131668. doi: 10.1016/j.biomaterials.2010.10.035.", "ArticleIdList": ["10.1016/j.biomaterials.2010.10.035", "21093905"]}, {"Citation": "Carvalho G.C., S\u00e1bio R.M., de C\u00e1ssia Ribeiro T., Monteiro A.S., Pereira D.V., Ribeiro S.J.L., Chorilli M. Highlights in Mesoporous Silica Nanoparticles as a Multifunctional Controlled Drug Delivery Nanoplatform for Infectious Diseases Treatment. Pharm. Res. 2020;37:191. doi: 10.1007/s11095-020-02917-6.", "ArticleIdList": ["10.1007/s11095-020-02917-6", "PMC7476752", "32895867"]}, {"Citation": "Petushkov A., Ndiege N., Salem A.K., Larsen S.C. Chapter 7\u2014Toxicity of Silica Nanomaterials: Zeolites, Mesoporous Silica, and Amorphous Silica Nanoparticles. In: Fishbein J.C., editor. Advances in Molecular Toxicology. Volume 4. Elsevier; Amsterdam, The Netherlands: 2010. pp. 223\u2013266."}, {"Citation": "Murugadoss S., Lison D., Godderis L., Van Den Brule S., Mast J., Brassinne F., Sebaihi N., Hoet P.H. Toxicology of silica nanoparticles: An update. Arch. Toxicol. 2017;91:2967\u20133010. doi: 10.1007/s00204-017-1993-y.", "ArticleIdList": ["10.1007/s00204-017-1993-y", "PMC5562771", "28573455"]}, {"Citation": "Croissant J.G., Fatieiev Y., Almalik A., Khashab N.M. Mesoporous Silica and Organosilica Nanoparticles: Physical Chemistry, Biosafety, Delivery Strategies, and Biomedical Applications. Adv. Healthc. Mater. 2018;7:1700831. doi: 10.1002/adhm.201700831.", "ArticleIdList": ["10.1002/adhm.201700831", "29193848"]}, {"Citation": "Nash T., Allison A.C., Harington J.S. Physico-Chemical Properties of Silica in Relation to its Toxicity. Nature. 1966;210:259\u2013261. doi: 10.1038/210259a0.", "ArticleIdList": ["10.1038/210259a0", "4289018"]}, {"Citation": "Zhang H., Dunphy D.R., Jiang X., Meng H., Sun B., Tarn D., Xue M., Wang X., Lin S., Ji Z., et al. Processing Pathway Dependence of Amorphous Silica Nanoparticle Toxicity: Colloidal vs Pyrolytic. J. Am. Chem. Soc. 2012;134:15790\u201315804. doi: 10.1021/ja304907c.", "ArticleIdList": ["10.1021/ja304907c", "PMC3505689", "22924492"]}, {"Citation": "Bhavsar D., Patel V., Sawant K. Systematic investigation of in vitro and in vivo safety, toxicity and degradation of mesoporous silica nanoparticles synthesized using commercial sodium silicate. Microporous Mesoporous Mater. 2019;284:343\u2013352. doi: 10.1016/j.micromeso.2019.04.050.", "ArticleIdList": ["10.1016/j.micromeso.2019.04.050"]}, {"Citation": "Rascol E., Daurat M., Da Silva A., Maynadier M., Dorandeu C., Charnay C., Garcia M., Lai-Kee-Him J., Bron P., Auffan M., et al. Biological Fate of Fe3O4 Core-Shell Mesoporous Silica Nanoparticles Depending on Particle Surface Chemistry. Nanomaterials. 2017;7:162. doi: 10.3390/nano7070162.", "ArticleIdList": ["10.3390/nano7070162", "PMC5535228", "28665317"]}, {"Citation": "Rascol E., Pisani C., Dorandeu C., Nyalosaso J.L., Charnay C., Daurat M., Da Silva A., Devoisselle J.-M., Gaillard J.-C., Armengaud J., et al. Biosafety of Mesoporous Silica Nanoparticles. Biomimetics. 2018;3:22. doi: 10.3390/biomimetics3030022.", "ArticleIdList": ["10.3390/biomimetics3030022", "PMC6352691", "31105244"]}, {"Citation": "Nasr S.S., Nasra M.M.A., Hazzah H.A., Abdallah O.Y. Mesoporous silica nanoparticles, a safe option for silymarin delivery: Preparation, characterization, and in vivo evaluation. Drug Deliv. Transl. Res. 2019;9:968\u2013979. doi: 10.1007/s13346-019-00640-3.", "ArticleIdList": ["10.1007/s13346-019-00640-3", "31001719"]}, {"Citation": "Rawat N., Sandhya, Subaharan K., Eswaramoorthy M., Kaul G. Comparative in vivo toxicity assessment places multiwalled carbon nanotubes at a higher level than mesoporous silica nanoparticles. Toxicol. Ind. Health. 2016;33:182\u2013192. doi: 10.1177/0748233715622307.", "ArticleIdList": ["10.1177/0748233715622307", "26818179"]}, {"Citation": "Lee S., Kim M.S., Lee D., Kwon T.K., Khang D., Yun H.S., Kim S.H. The comparative immunotoxicity of mesoporous silica nanoparticles and colloidal silica nanoparticles in mice. Int. J. Nanomed. 2013;8:147\u2013158. doi: 10.2147/ijn.s39534.", "ArticleIdList": ["10.2147/ijn.s39534", "PMC3544348", "23326190"]}, {"Citation": "Limnell T., Santos H.A., M\u00e4kil\u00e4 E., Heikkil\u00e4 T., Salonen J., Murzin D.Y., Kumar N., Laaksonen T., Peltonen L., Hirvonen J. Drug delivery formulations of ordered and nonordered mesoporous silica: Comparison of three drug loading methods. J. Pharm. Sci. 2011;100:3294\u20133306. doi: 10.1002/jps.22577.", "ArticleIdList": ["10.1002/jps.22577", "21520084"]}, {"Citation": "Rosenholm J.M., Lind\u00e9n M. Towards establishing structure-activity relationships for mesoporous silica in drug delivery applications. J. Control. Release. 2008;128:157\u2013164. doi: 10.1016/j.jconrel.2008.02.013.", "ArticleIdList": ["10.1016/j.jconrel.2008.02.013", "18439699"]}, {"Citation": "Zhang Z., Wang L., Wang J., Jiang X., Li X., Hu Z., Ji Y., Wu X., Chen C. Mesoporous Silica-Coated Gold Nanorods as a Light-Mediated Multifunctional Theranostic Platform for Cancer Treatment. Adv. Mater. 2012;24:1418\u20131423. doi: 10.1002/adma.201104714.", "ArticleIdList": ["10.1002/adma.201104714", "22318874"]}, {"Citation": "She X., Chen L., Li C., He C., He L., Kong L. Functionalization of Hollow Mesoporous Silica Nanoparticles for Improved 5-FU Loading. J. Nanomater. 2015;2015:872035. doi: 10.1155/2015/872035.", "ArticleIdList": ["10.1155/2015/872035"]}, {"Citation": "Doadrio J.C., Sousa E.M.B., Izquierdo-Barba I., Doadrio A.L., Perez-Pariente J., Vallet-Reg\u00ed M. Functionalization of mesoporous materials with long alkyl chains as a strategy for controlling drug delivery pattern. J. Mater. Chem. 2006;16:462\u2013466. doi: 10.1039/B510101H.", "ArticleIdList": ["10.1039/B510101H"]}, {"Citation": "Balas F., Manzano M., Horcajada P., Vallet-Reg\u00ed M. Confinement and Controlled Release of Bisphosphonates on Ordered Mesoporous Silica-Based Materials. J. Am. Chem. Soc. 2006;128:8116\u20138117. doi: 10.1021/ja062286z.", "ArticleIdList": ["10.1021/ja062286z", "16787058"]}, {"Citation": "Ibrahim A.H., Sm\u00e5tt J.-H., Govardhanam N.P., Ibrahim H.M., Ismael H.R., Afouna M.I., Samy A.M., Rosenholm J.M. Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin. Eur. J. Pharm. Sci. 2020;142:105103. doi: 10.1016/j.ejps.2019.105103.", "ArticleIdList": ["10.1016/j.ejps.2019.105103", "31648050"]}, {"Citation": "He Y., Liang S., Long M., Xu H. Mesoporous silica nanoparticles as potential carriers for enhanced drug solubility of paclitaxel. Mater. Sci. Eng. C. 2017;78:12\u201317. doi: 10.1016/j.msec.2017.04.049.", "ArticleIdList": ["10.1016/j.msec.2017.04.049", "28575958"]}, {"Citation": "Zhou Y., Quan G., Wu Q., Zhang X., Niu B., Wu B., Huang Y., Pan X., Wu C. Mesoporous silica nanoparticles for drug and gene delivery. Acta Pharm. Sin. B. 2018;8:165\u2013177. doi: 10.1016/j.apsb.2018.01.007.", "ArticleIdList": ["10.1016/j.apsb.2018.01.007", "PMC5926503", "29719777"]}, {"Citation": "Cheng C.-A., Deng T., Lin F.-C., Cai Y., Zink J.I. Supramolecular Nanomachines as Stimuli-Responsive Gatekeepers on Mesoporous Silica Nanoparticles for Antibiotic and Cancer Drug Delivery. Theranostics. 2019;9:3341\u20133364. doi: 10.7150/thno.34576.", "ArticleIdList": ["10.7150/thno.34576", "PMC6567974", "31244957"]}, {"Citation": "Torney F., Trewyn B.G., Lin V.S.Y., Wang K. Mesoporous silica nanoparticles deliver DNA and chemicals into plants. Nat. Nanotechnol. 2007;2:295\u2013300. doi: 10.1038/nnano.2007.108.", "ArticleIdList": ["10.1038/nnano.2007.108", "18654287"]}, {"Citation": "Giri S., Trewyn B.G., Stellmaker M.P., Lin V.S.Y. Stimuli-Responsive Controlled-Release Delivery System Based on Mesoporous Silica Nanorods Capped with Magnetic Nanoparticles. Angew. Chem. Int. Ed. 2005;44:5038\u20135044. doi: 10.1002/anie.200501819.", "ArticleIdList": ["10.1002/anie.200501819", "16038000"]}, {"Citation": "Slowing I.I., Vivero-Escoto J.L., Trewyn B.G., Lin V.S.Y. Mesoporous silica nanoparticles: Structural design and applications. J. Mater. Chem. 2010;20:7924\u20137937. doi: 10.1039/c0jm00554a.", "ArticleIdList": ["10.1039/c0jm00554a"]}, {"Citation": "Lai C.-Y., Trewyn B.G., Jeftinija D.M., Jeftinija K., Xu S., Jeftinija S., Lin V.S.Y. A Mesoporous Silica Nanosphere-Based Carrier System with Chemically Removable CdS Nanoparticle Caps for Stimuli-Responsive Controlled Release of Neurotransmitters and Drug Molecules. J. Am. Chem. Soc. 2003;125:4451\u20134459. doi: 10.1021/ja028650l.", "ArticleIdList": ["10.1021/ja028650l", "12683815"]}, {"Citation": "Chang B., Sha X., Guo J., Jiao Y., Wang C., Yang W. Thermo and pH dual responsive, polymer shell coated, magnetic mesoporous silica nanoparticles for controlled drug release. J. Mater. Chem. 2011;21:9239\u20139247. doi: 10.1039/c1jm10631g.", "ArticleIdList": ["10.1039/c1jm10631g"]}, {"Citation": "Chang B., Chen D., Wang Y., Chen Y., Jiao Y., Sha X., Yang W. Bioresponsive Controlled Drug Release Based on Mesoporous Silica Nanoparticles Coated with Reductively Sheddable Polymer Shell. Chem. Mater. 2013;25:574\u2013585. doi: 10.1021/cm3037197.", "ArticleIdList": ["10.1021/cm3037197"]}, {"Citation": "Croissant J.G., Zhang D., Alsaiari S., Lu J., Deng L., Tamanoi F., AlMalik A.M., Zink J.I., Khashab N.M. Protein-gold clusters-capped mesoporous silica nanoparticles for high drug loading, autonomous gemcitabine/doxorubicin co-delivery, and in-vivo tumor imaging. J. Control. Release. 2016;229:183\u2013191. doi: 10.1016/j.jconrel.2016.03.030.", "ArticleIdList": ["10.1016/j.jconrel.2016.03.030", "27016140"]}, {"Citation": "Saleh T., Soudi T., Shojaosadati S.A. Aptamer functionalized curcumin-loaded human serum albumin (HSA) nanoparticles for targeted delivery to HER-2 positive breast cancer cells. Int. J. Biol. Macromol. 2019;130:109\u2013116. doi: 10.1016/j.ijbiomac.2019.02.129.", "ArticleIdList": ["10.1016/j.ijbiomac.2019.02.129", "30802519"]}, {"Citation": "Iraji S., Ganji F., Rashidi L. Surface modified mesoporous silica nanoparticles as sustained-release gallic acid nano-carriers. J. Drug Deliv. Sci. Technol. 2018;47:468\u2013476. doi: 10.1016/j.jddst.2018.08.008.", "ArticleIdList": ["10.1016/j.jddst.2018.08.008"]}, {"Citation": "Ma\u2019mani L., Nikzad S., Kheiri-Manjili H., Al-Musawi S., Saeedi M., Askarlou S., Foroumadi A., Shafiee A. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: Practical strategy for the breast cancer therapy. Eur. J. Med. Chem. 2014;83:646\u2013654. doi: 10.1016/j.ejmech.2014.06.069.", "ArticleIdList": ["10.1016/j.ejmech.2014.06.069", "25014638"]}, {"Citation": "Szegedi \u00c1., Shestakova P., Trendafilova I., Mihayi J., Tsacheva I., Mitova V., Kyulavska M., Koseva N., Momekova D., Konstantinov S., et al. Modified mesoporous silica nanoparticles coated by polymer complex as novel curcumin delivery carriers. J. Drug Deliv. Sci. Technol. 2019;49:700\u2013712. doi: 10.1016/j.jddst.2018.12.016.", "ArticleIdList": ["10.1016/j.jddst.2018.12.016"]}, {"Citation": "Sattary M., Amini J., Hallaj R. Antifungal activity of the lemongrass and clove oil encapsulated in mesoporous silica nanoparticles against wheat\u2019s take-all disease. Pestic. Biochem. Physiol. 2020;170:104696. doi: 10.1016/j.pestbp.2020.104696.", "ArticleIdList": ["10.1016/j.pestbp.2020.104696", "32980050"]}, {"Citation": "Song Y., Zhou B., Du X., Wang Y., Zhang J., Ai Y., Xia Z., Zhao G. Folic acid (FA)-conjugated mesoporous silica nanoparticles combined with MRP-1 siRNA improves the suppressive effects of myricetin on non-small cell lung cancer (NSCLC) Biomed. Pharmacother. 2020;125:109561. doi: 10.1016/j.biopha.2019.109561.", "ArticleIdList": ["10.1016/j.biopha.2019.109561", "32106385"]}, {"Citation": "Li T., Chen X., Liu Y., Fan L., Lin L., Xu Y., Chen S., Shao J. pH-Sensitive mesoporous silica nanoparticles anticancer prodrugs for sustained release of ursolic acid and the enhanced anti-cancer efficacy for hepatocellular carcinoma cancer. Eur. J. Pharm. Sci. 2017;96:456\u2013463. doi: 10.1016/j.ejps.2016.10.019.", "ArticleIdList": ["10.1016/j.ejps.2016.10.019", "27771513"]}, {"Citation": "Lungare S., Hallam K., Badhan R.K.S. Phytochemical-loaded mesoporous silica nanoparticles for nose-to-brain olfactory drug delivery. Int. J. Pharm. 2016;513:280\u2013293. doi: 10.1016/j.ijpharm.2016.09.042.", "ArticleIdList": ["10.1016/j.ijpharm.2016.09.042", "27633279"]}, {"Citation": "Sapino S., Ugazio E., Gastaldi L., Miletto I., Berlier G., Zonari D., Oliaro-Bosso S. Mesoporous silica as topical nanocarriers for quercetin: Characterization and in vitro studies. Eur. J. Pharm. Biopharm. 2015;89:116\u2013125. doi: 10.1016/j.ejpb.2014.11.022.", "ArticleIdList": ["10.1016/j.ejpb.2014.11.022", "25478737"]}, {"Citation": "Kundu M., Chatterjee S., Ghosh N., Manna P., Das J., Sil P.C. Tumor targeted delivery of umbelliferone via a smart mesoporous silica nanoparticles controlled-release drug delivery system for increased anticancer efficiency. Mater. Sci. Eng. C. 2020;116:111239. doi: 10.1016/j.msec.2020.111239.", "ArticleIdList": ["10.1016/j.msec.2020.111239", "32806268"]}, {"Citation": "Zhao Q., Wu B., Shang Y., Huang X., Dong H., Liu H., Chen W., Gui R., Li J. Development of a nano-drug delivery system based on mesoporous silica and its anti-lymphoma activity. Appl. Nanosci. 2020;10:3431\u20133442. doi: 10.1007/s13204-020-01465-0.", "ArticleIdList": ["10.1007/s13204-020-01465-0"]}, {"Citation": "Angelos S., Khashab N.M., Yang Y.-W., Trabolsi A., Khatib H.A., Stoddart J.F., Zink J.I. pH Clock-Operated Mechanized Nanoparticles. J. Am. Chem. Soc. 2009;131:12912\u201312914. doi: 10.1021/ja9010157.", "ArticleIdList": ["10.1021/ja9010157", "19705840"]}, {"Citation": "Patel K., Angelos S., Dichtel W.R., Coskun A., Yang Y.-W., Zink J.I., Stoddart J.F. Enzyme-Responsive Snap-Top Covered Silica Nanocontainers. J. Am. Chem. Soc. 2008;130:2382\u20132383. doi: 10.1021/ja0772086.", "ArticleIdList": ["10.1021/ja0772086", "18232687"]}, {"Citation": "Hernandez R., Tseng H.-R., Wong J.W., Stoddart J.F., Zink J.I. An Operational Supramolecular Nanovalve. J. Am. Chem. Soc. 2004;126:3370\u20133371. doi: 10.1021/ja039424u.", "ArticleIdList": ["10.1021/ja039424u", "15025433"]}, {"Citation": "Angelos S., Johansson E., Stoddart J.F., Zink J.I. Mesostructured Silica Supports for Functional Materials and Molecular Machines. Adv. Funct. Mater. 2007;17:2261\u20132271. doi: 10.1002/adfm.200601217.", "ArticleIdList": ["10.1002/adfm.200601217"]}, {"Citation": "Khashab N.M., Belowich M.E., Trabolsi A., Friedman D.C., Valente C., Lau Y., Khatib H.A., Zink J.I., Stoddart J.F. pH-Responsive mechanised nanoparticles gated by semirotaxanes. Chem. Commun. 2009:5371\u20135373. doi: 10.1039/b910431c.", "ArticleIdList": ["10.1039/b910431c", "19724788"]}, {"Citation": "Croissant J., Zink J.I. Nanovalve-Controlled Cargo Release Activated by Plasmonic Heating. J. Am. Chem. Soc. 2012;134:7628\u20137631. doi: 10.1021/ja301880x.", "ArticleIdList": ["10.1021/ja301880x", "PMC3800183", "22540671"]}, {"Citation": "Croissant J., Chaix A., Mongin O., Wang M., Cl\u00e9ment S., Raehm L., Durand J.-O., Hugues V., Blanchard-Desce M., Maynadier M., et al. Two-Photon-Triggered Drug Delivery via Fluorescent Nanovalves. Small. 2014;10:1752\u20131755. doi: 10.1002/smll.201400042.", "ArticleIdList": ["10.1002/smll.201400042", "24678053"]}, {"Citation": "Ambrogio M.W., Thomas C.R., Zhao Y.-L., Zink J.I., Stoddart J.F. Mechanized Silica Nanoparticles: A New Frontier in Theranostic Nanomedicine. Acc. Chem. Res. 2011;44:903\u2013913. doi: 10.1021/ar200018x.", "ArticleIdList": ["10.1021/ar200018x", "PMC3196789", "21675720"]}, {"Citation": "Gan Q., Lu X., Yuan Y., Qian J., Zhou H., Shi J., Liu C. A magnetic, reversible pH-responsive nanogated ensemble based on Fe3O4 nanoparticles-capped mesoporous silica. Biomaterials. 2011;32:1932\u20131942. doi: 10.1016/j.biomaterials.2010.11.020.", "ArticleIdList": ["10.1016/j.biomaterials.2010.11.020", "21131045"]}, {"Citation": "Liu R., Zhang Y., Zhao X., Agarwal A., Mueller L.J., Feng P. pH-responsive nanogated ensemble based on gold-capped mesoporous silica through an acid-labile acetal linker. J. Am. Chem. Soc. 2010;132:1500\u20131501. doi: 10.1021/ja907838s.", "ArticleIdList": ["10.1021/ja907838s", "20085351"]}, {"Citation": "Liu M., Sun X., Liao Z., Li Y., Qi X., Qian Y., Fenniri H., Zhao P., Shen J. Zinc oxide end-capped Fe(3)O(4)@mSiO(2) core-shell nanocarriers as targeted and responsive drug delivery system for chemo-/ions synergistic therapeutics. Drug Deliv. 2019;26:732\u2013743. doi: 10.1080/10717544.2019.1642419.", "ArticleIdList": ["10.1080/10717544.2019.1642419", "PMC6713220", "31340678"]}, {"Citation": "Liu M.C., Liu B., Chen X.L., Lin H.C., Sun X.Y., Lu J.Z., Li Y.Y., Yan S.Q., Zhang L.Y., Zhao P. Calcium carbonate end-capped, folate-mediated Fe(3)O(4)@mSiO(2) core-shell nanocarriers as targeted controlled-release drug delivery system. J. Biomater. Appl. 2018;32:1090\u20131104. doi: 10.1177/0885328217752994.", "ArticleIdList": ["10.1177/0885328217752994", "29357775"]}, {"Citation": "Butler K.S., Durfee P.N., Theron C., Ashley C.E., Carnes E.C., Brinker C.J. Protocells: Modular Mesoporous Silica Nanoparticle-Supported Lipid Bilayers for Drug Delivery. Small. 2016;12:2173\u20132185. doi: 10.1002/smll.201502119.", "ArticleIdList": ["10.1002/smll.201502119", "PMC4964272", "26780591"]}, {"Citation": "Kumar P., Tambe P., Paknikar K.M., Gajbhiye V. Mesoporous silica nanoparticles as cutting-edge theranostics: Advancement from merely a carrier to tailor-made smart delivery platform. J. Control. Release. 2018;287:35\u201357. doi: 10.1016/j.jconrel.2018.08.024.", "ArticleIdList": ["10.1016/j.jconrel.2018.08.024", "30125637"]}, {"Citation": "Bakhshian Nik A., Zare H., Razavi S., Mohammadi H., Torab Ahmadi P., Yazdani N., Bayandori M., Rabiee N., Izadi Mobarakeh J. Smart drug delivery: Capping strategies for mesoporous silica nanoparticles. Microporous Mesoporous Mater. 2020;299:110115. doi: 10.1016/j.micromeso.2020.110115.", "ArticleIdList": ["10.1016/j.micromeso.2020.110115"]}, {"Citation": "Baeza A., Colilla M., Vallet-Reg\u00ed M. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery. Expert Opin. Drug Deliv. 2015;12:319\u2013337. doi: 10.1517/17425247.2014.953051.", "ArticleIdList": ["10.1517/17425247.2014.953051", "25421898"]}, {"Citation": "Manzano M., Vallet-Reg\u00ed M. Mesoporous silica nanoparticles in nanomedicine applications. J. Mater. Sci. Mater. Med. 2018;29:65. doi: 10.1007/s10856-018-6069-x.", "ArticleIdList": ["10.1007/s10856-018-6069-x", "29737405"]}, {"Citation": "Ahmadi Nasab N., Hassani Kumleh H., Beygzadeh M., Teimourian S., Kazemzad M. Delivery of curcumin by a pH-responsive chitosan mesoporous silica nanoparticles for cancer treatment. Artif. Cellsnanomed. Biotechnol. 2018;46:75\u201381. doi: 10.1080/21691401.2017.1290648.", "ArticleIdList": ["10.1080/21691401.2017.1290648", "28278578"]}, {"Citation": "Mishra S., Manna K., Kayal U., Saha M., Chatterjee S., Chandra D., Hara M., Datta S., Bhaumik A., Das Saha K. Folic acid-conjugated magnetic mesoporous silica nanoparticles loaded with quercetin: A theranostic approach for cancer management. RSC Adv. 2020;10:23148\u201323164. doi: 10.1039/D0RA00664E.", "ArticleIdList": ["10.1039/D0RA00664E", "PMC9054720", "35520307"]}, {"Citation": "Rashidi L., Vasheghani-Farahani E., Rostami K., Ganji F., Fallahpour M. Mesoporous silica nanoparticles with different pore sizes for delivery of pH-sensitive gallic acid. Asia-Pac. J. Chem. Eng. 2014;9:845\u2013853. doi: 10.1002/apj.1832.", "ArticleIdList": ["10.1002/apj.1832"]}, {"Citation": "Feng Y., Li N.-X., Yin H.-L., Chen T.-Y., Yang Q., Wu M. Thermo- and pH-responsive, Lipid-coated, Mesoporous Silica Nanoparticle-based Dual Drug Delivery System To Improve the Antitumor Effect of Hydrophobic Drugs. Mol. Pharm. 2019;16:422\u2013436. doi: 10.1021/acs.molpharmaceut.8b01073.", "ArticleIdList": ["10.1021/acs.molpharmaceut.8b01073", "30525641"]}, {"Citation": "Fu J., Zhu Y. Lysosomes activating chain reactions against cancer cells with a pH-switched prodrug/procatalyst co-delivery nanosystem. J. Mater. Chem. B. 2017;5:996\u20131004. doi: 10.1039/C6TB02820A.", "ArticleIdList": ["10.1039/C6TB02820A", "32263878"]}, {"Citation": "Russo A., DeGraff W., Friedman N., Mitchell J.B. Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs. Cancer Res. 1986;46:2845\u20132848.", "ArticleIdList": ["2421885"]}, {"Citation": "Lin J.-T., Ye Q.-B., Yang Q.-J., Wang G.-H. Hierarchical bioresponsive nanocarriers for codelivery of curcumin and doxorubicin. Colloids Surf. B Biointerfaces. 2019;180:93\u2013101. doi: 10.1016/j.colsurfb.2019.04.023.", "ArticleIdList": ["10.1016/j.colsurfb.2019.04.023", "31035057"]}, {"Citation": "Xu X., L\u00fc S., Gao C., Feng C., Wu C., Bai X., Gao N., Wang Z., Liu M. Self-fluorescent and stimuli-responsive mesoporous silica nanoparticles using a double-role curcumin gatekeeper for drug delivery. Chem. Eng. J. 2016;300:185\u2013192. doi: 10.1016/j.cej.2016.04.087.", "ArticleIdList": ["10.1016/j.cej.2016.04.087"]}, {"Citation": "Vaghasiya K., Ray E., Sharma A., Katare O.P., Verma R.K. Matrix Metalloproteinase-Responsive Mesoporous Silica Nanoparticles Cloaked with Cleavable Protein for \u201cSelf-Actuating\u201d On-Demand Controlled Drug Delivery for Cancer Therapy. ACS Appl. Bio Mater. 2020;3:4987\u20134999. doi: 10.1021/acsabm.0c00497.", "ArticleIdList": ["10.1021/acsabm.0c00497", "35021676"]}, {"Citation": "Baeza A., Guisasola E., Ruiz-Hern\u00e1ndez E., Vallet-Reg\u00ed M. Magnetically Triggered Multidrug Release by Hybrid Mesoporous Silica Nanoparticles. Chem. Mater. 2012;24:517\u2013524. doi: 10.1021/cm203000u.", "ArticleIdList": ["10.1021/cm203000u"]}, {"Citation": "Wang Z., Wang Y.S., Chang Z.M., Li L., Zhang Y., Lu M.M., Zheng X., Li M., Shao D., Li J., et al. Berberine-loaded Janus nanocarriers for magnetic field-enhanced therapy against hepatocellular carcinoma. Chem. Biol. Drug Des. 2017;89:464\u2013469. doi: 10.1111/cbdd.12866.", "ArticleIdList": ["10.1111/cbdd.12866", "27618577"]}, {"Citation": "Asgari M., Miri T., Soleymani M., Barati A. A novel method for in situ encapsulation of curcumin in magnetite-silica core-shell nanocomposites: A multifunctional platform for drug delivery and magnetic hyperthermia therapy. J. Mol. Liq. 2020:114731. doi: 10.1016/j.molliq.2020.114731.", "ArticleIdList": ["10.1016/j.molliq.2020.114731"]}, {"Citation": "Zhu Y., Tao C. DNA-capped Fe3O4/SiO2 magnetic mesoporous silica nanoparticles for potential controlled drug release and hyperthermia. RSC Adv. 2015;5:22365\u201322372. doi: 10.1039/C5RA00701A.", "ArticleIdList": ["10.1039/C5RA00701A"]}, {"Citation": "Mal N.K., Fujiwara M., Tanaka Y. Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica. Nature. 2003;421:350\u2013353. doi: 10.1038/nature01362.", "ArticleIdList": ["10.1038/nature01362", "12540896"]}, {"Citation": "Ferris D.P., Zhao Y.-L., Khashab N.M., Khatib H.A., Stoddart J.F., Zink J.I. Light-Operated Mechanized Nanoparticles. J. Am. Chem. Soc. 2009;131:1686\u20131688. doi: 10.1021/ja807798g.", "ArticleIdList": ["10.1021/ja807798g", "19159224"]}, {"Citation": "Mart\u00ednez-Carmona M., Baeza A., Rodriguez-Milla M.A., Garc\u00eda-Castro J., Vallet-Reg\u00ed M. Mesoporous silica nanoparticles grafted with a light-responsive protein shell for highly cytotoxic antitumoral therapy. J. Mater. Chem. B. 2015;3:5746\u20135752. doi: 10.1039/C5TB00304K.", "ArticleIdList": ["10.1039/C5TB00304K", "32262570"]}, {"Citation": "Kuang G., Zhang Q., He S., Liu Y. Curcumin-loaded PEGylated mesoporous silica nanoparticles for effective photodynamic therapy. RSC Adv. 2020;10:24624\u201324630. doi: 10.1039/D0RA04778C.", "ArticleIdList": ["10.1039/D0RA04778C", "PMC9055143", "35516169"]}, {"Citation": "Li X.D., Wang Z., Wang X.R., Shao D., Zhang X., Li L., Ge M.F., Chang Z.M., Dong W.F. Berberine-loaded Janus gold mesoporous silica nanocarriers for chemo/radio/photothermal therapy of liver cancer and radiation-induced injury inhibition. Int. J. Nanomed. 2019;14:3967\u20133982. doi: 10.2147/IJN.S206044.", "ArticleIdList": ["10.2147/IJN.S206044", "PMC6554520", "31239666"]}, {"Citation": "Yu T., Tong L., Ao Y., Zhang G., Liu Y., Zhang H. Novel design of NIR-triggered plasmonic nanodots capped mesoporous silica nanoparticles loaded with natural capsaicin to inhibition of metastasis of human papillary thyroid carcinoma B-CPAP cells in thyroid cancer chemo-photothermal therapy. J. Photochem. Photobiol. B. 2019;197:111534. doi: 10.1016/j.jphotobiol.2019.111534.", "ArticleIdList": ["10.1016/j.jphotobiol.2019.111534", "31279897"]}, {"Citation": "Sirsi S.R., Borden M.A. State-of-the-art materials for ultrasound-triggered drug delivery. Adv. Drug Deliv. Rev. 2014;72:3\u201314. doi: 10.1016/j.addr.2013.12.010.", "ArticleIdList": ["10.1016/j.addr.2013.12.010", "PMC4041842", "24389162"]}, {"Citation": "Wang J., Pelletier M., Zhang H., Xia H., Zhao Y. High-Frequency Ultrasound-Responsive Block Copolymer Micelle. Langmuir. 2009;25:13201\u201313205. doi: 10.1021/la9018794.", "ArticleIdList": ["10.1021/la9018794", "19572509"]}, {"Citation": "Paris J.L., Caba\u00f1as M.V., Manzano M., Vallet-Reg\u00ed M. Polymer-Grafted Mesoporous Silica Nanoparticles as Ultrasound-Responsive Drug Carriers. ACS Nano. 2015;9:11023\u201311033. doi: 10.1021/acsnano.5b04378.", "ArticleIdList": ["10.1021/acsnano.5b04378", "26456489"]}, {"Citation": "Paris J.L., de la Torre P., Victoria Caba\u00f1as M., Manzano M., Grau M., Flores A.I., Vallet-Reg\u00ed M. Vectorization of ultrasound-responsive nanoparticles in placental mesenchymal stem cells for cancer therapy. Nanoscale. 2017;9:5528\u20135537. doi: 10.1039/C7NR01070B.", "ArticleIdList": ["10.1039/C7NR01070B", "28402365"]}, {"Citation": "Li X., Wang Z., Xia H. Ultrasound Reversible Response Nanocarrier Based on Sodium Alginate Modified Mesoporous Silica Nanoparticles. Front. Chem. 2019;7:59. doi: 10.3389/fchem.2019.00059.", "ArticleIdList": ["10.3389/fchem.2019.00059", "PMC6378627", "30805332"]}, {"Citation": "Luo Z., Ding X., Hu Y., Wu S., Xiang Y., Zeng Y., Zhang B., Yan H., Zhang H., Zhu L., et al. Engineering a Hollow Nanocontainer Platform with Multifunctional Molecular Machines for Tumor-Targeted Therapy in Vitro and in Vivo. ACS Nano. 2013;7:10271\u201310284. doi: 10.1021/nn404676w.", "ArticleIdList": ["10.1021/nn404676w", "24127723"]}, {"Citation": "Matsumura Y., Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986;46:6387\u20136392.", "ArticleIdList": ["2946403"]}, {"Citation": "Nakamura H., Fang J., Maeda H. Development of next-generation macromolecular drugs based on the EPR effect: Challenges and pitfalls. Expert Opin. Drug Deliv. 2015;12:53\u201364. doi: 10.1517/17425247.2014.955011.", "ArticleIdList": ["10.1517/17425247.2014.955011", "25425260"]}, {"Citation": "Danhier F., Feron O., Pr\u00e9at V. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J. Control. Release. 2010;148:135\u2013146. doi: 10.1016/j.jconrel.2010.08.027.", "ArticleIdList": ["10.1016/j.jconrel.2010.08.027", "20797419"]}, {"Citation": "Peer D., Karp J.M., Hong S., Farokhzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2007;2:751\u2013760. doi: 10.1038/nnano.2007.387.", "ArticleIdList": ["10.1038/nnano.2007.387", "18654426"]}, {"Citation": "Philipp A., Meyer M., Wagner E. Extracellular targeting of synthetic therapeutic nucleic acid formulations. Curr. Gene. 2008;8:324\u2013334. doi: 10.2174/156652308786071023.", "ArticleIdList": ["10.2174/156652308786071023", "18855630"]}, {"Citation": "Ang C.Y., Tan S.Y., Zhao Y. Recent advances in biocompatible nanocarriers for delivery of chemotherapeutic cargoes towards cancer therapy. Org. Biomol. Chem. 2014;12:4776\u20134806. doi: 10.1039/c4ob00164h.", "ArticleIdList": ["10.1039/c4ob00164h", "24737243"]}, {"Citation": "Mickler F.M., M\u00f6ckl L., Ruthardt N., Ogris M., Wagner E., Br\u00e4uchle C. Tuning nanoparticle uptake: Live-cell imaging reveals two distinct endocytosis mechanisms mediated by natural and artificial EGFR targeting ligand. Nano Lett. 2012;12:3417\u20133423. doi: 10.1021/nl300395q.", "ArticleIdList": ["10.1021/nl300395q", "22632479"]}, {"Citation": "Rosenholm J.M., Peuhu E., Bate-Eya L.T., Eriksson J.E., Sahlgren C., Lind\u00e9n M. Cancer-Cell-Specific Induction of Apoptosis Using Mesoporous Silica Nanoparticles as Drug-Delivery Vectors. Small. 2010;6:1234\u20131241. doi: 10.1002/smll.200902355.", "ArticleIdList": ["10.1002/smll.200902355", "20486218"]}, {"Citation": "Zhang J., Yuan Z.F., Wang Y., Chen W.H., Luo G.F., Cheng S.X., Zhuo R.X., Zhang X.Z. Multifunctional envelope-type mesoporous silica nanoparticles for tumor-triggered targeting drug delivery. J. Am. Chem. Soc. 2013;135:5068\u20135073. doi: 10.1021/ja312004m.", "ArticleIdList": ["10.1021/ja312004m", "23464924"]}, {"Citation": "Shen Y., Li M., Liu T., Liu J., Xie Y., Zhang J., Xu S., Liu H. A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells. Int. J. Nanomed. 2019;14:4029\u20134044. doi: 10.2147/IJN.S201688.", "ArticleIdList": ["10.2147/IJN.S201688", "PMC6549788", "31213813"]}, {"Citation": "Zhao Q., Liu J., Zhu W., Sun C., Di D., Zhang Y., Wang P., Wang Z., Wang S. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells. Acta Biomater. 2015;23:147\u2013156. doi: 10.1016/j.actbio.2015.05.010.", "ArticleIdList": ["10.1016/j.actbio.2015.05.010", "25985912"]}, {"Citation": "Brevet D., Gary-Bobo M., Raehm L., Richeter S., Hocine O., Amro K., Loock B., Couleaud P., Frochot C., Mor\u00e8re A., et al. Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy. Chem. Commun. 2009:1475\u20131477. doi: 10.1039/b900427k.", "ArticleIdList": ["10.1039/b900427k", "19277361"]}, {"Citation": "Gisbert-Garzar\u00e1n M., Vallet-Reg\u00ed M. Influence of the Surface Functionalization on the Fate and Performance of Mesoporous Silica Nanoparticles. Nanomaterials. 2020;10:916. doi: 10.3390/nano10050916.", "ArticleIdList": ["10.3390/nano10050916", "PMC7279540", "32397449"]}, {"Citation": "Li N., Wang Z., Zhang Y., Zhang K., Xie J., Liu Y., Li W., Feng N. Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy. Artif. Cells Nanomed. Biotechnol. 2018;46:921\u2013935. doi: 10.1080/21691401.2018.1473412.", "ArticleIdList": ["10.1080/21691401.2018.1473412", "29790797"]}, {"Citation": "Malekmohammadi S., Hadadzadeh H., Farrokhpour H., Amirghofran Z. Immobilization of gold nanoparticles on folate-conjugated dendritic mesoporous silica-coated reduced graphene oxide nanosheets: A new nanoplatform for curcumin pH-controlled and targeted delivery. Soft Matter. 2018;14:2400\u20132410. doi: 10.1039/C7SM02248D.", "ArticleIdList": ["10.1039/C7SM02248D", "29512668"]}, {"Citation": "Fang J., Zhang S., Xue X., Zhu X., Song S., Wang B., Jiang L., Qin M., Liang H., Gao L. Quercetin and doxorubicin co-delivery using mesoporous silica nanoparticles enhance the efficacy of gastric carcinoma chemotherapy. Int. J. Nanomed. 2018;13:5113\u20135126. doi: 10.2147/IJN.S170862.", "ArticleIdList": ["10.2147/IJN.S170862", "PMC6135215", "30233175"]}, {"Citation": "Kumar B.N.P., Puvvada N., Rajput S., Sarkar S., Mahto M.K., Yallapu M.M., Pathak A., Emdad L., Das S.K., Reis R.L., et al. Targeting of EGFR, VEGFR2, and Akt by Engineered Dual Drug Encapsulated Mesoporous Silica-Gold Nanoclusters Sensitizes Tamoxifen-Resistant Breast Cancer. Mol. Pharm. 2018;15:2698\u20132713. doi: 10.1021/acs.molpharmaceut.8b00218.", "ArticleIdList": ["10.1021/acs.molpharmaceut.8b00218", "29787277"]}, {"Citation": "Murugan C., Rayappan K., Thangam R., Bhanumathi R., Shanthi K., Vivek R., Thirumurugan R., Bhattacharyya A., Sivasubramanian S., Gunasekaran P., et al. Combinatorial nanocarrier based drug delivery approach for amalgamation of anti-tumor agents in breast cancer cells: An improved nanomedicine strategy. Sci. Rep. 2016;6:34053. doi: 10.1038/srep34053.", "ArticleIdList": ["10.1038/srep34053", "PMC5057072", "27725731"]}, {"Citation": "Sarkar A., Ghosh S., Chowdhury S., Pandey B., Sil P.C. Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells. Biochim. Biophys. Acta. 2016;1860:2065\u20132075. doi: 10.1016/j.bbagen.2016.07.001.", "ArticleIdList": ["10.1016/j.bbagen.2016.07.001", "27392941"]}, {"Citation": "Ding J., Yao J., Xue J., Li R., Bao B., Jiang L., Zhu J.J., He Z. Tumor-Homing Cell-Penetrating Peptide Linked to Colloidal Mesoporous Silica Encapsulated (-)-Epigallocatechin-3-gallate as Drug Delivery System for Breast Cancer Therapy in Vivo. ACS Appl. Mater. Interfaces. 2015;7:18145\u201318155. doi: 10.1021/acsami.5b05618.", "ArticleIdList": ["10.1021/acsami.5b05618", "26225796"]}, {"Citation": "Hu Y., Wang Z., Qiu Y., Liu Y., Ding M., Zhang Y. Anti-miRNA21 and resveratrol-loaded polysaccharide-based mesoporous silica nanoparticle for synergistic activity in gastric carcinoma. J. Drug Target. 2019;27:1135\u20131143. doi: 10.1080/1061186X.2019.1610766.", "ArticleIdList": ["10.1080/1061186X.2019.1610766", "31017473"]}, {"Citation": "Del Favero G., Bialas F., Grabher S., Wittig A., Br\u00e4uer B., Gerthsen D., Echalier C., Kamalov M., Marko D., Becker C.F.W. Silica particles with a quercetin\u2013R5 peptide conjugate are taken up into HT-29 cells and translocate into the nucleus. Chem. Commun. 2019;55:9649\u20139652. doi: 10.1039/C9CC02215E.", "ArticleIdList": ["10.1039/C9CC02215E", "31339160"]}, {"Citation": "Havel H.A. Where Are the Nanodrugs? An Industry Perspective on Development of Drug Products Containing Nanomaterials. AAPS J. 2016;18:1351\u20131353. doi: 10.1208/s12248-016-9970-6.", "ArticleIdList": ["10.1208/s12248-016-9970-6", "27520380"]}, {"Citation": "Havel H., Finch G., Strode P., Wolfgang M., Zale S., Bobe I., Youssoufian H., Peterson M., Liu M. Nanomedicines: From Bench to Bedside and Beyond. AAPS J. 2016;18:1373\u20131378. doi: 10.1208/s12248-016-9961-7.", "ArticleIdList": ["10.1208/s12248-016-9961-7", "27480318"]}, {"Citation": "Tran S., DeGiovanni P.J., Piel B., Rai P. Cancer nanomedicine: A review of recent success in drug delivery. Clin. Transl. Med. 2017;6:44. doi: 10.1186/s40169-017-0175-0.", "ArticleIdList": ["10.1186/s40169-017-0175-0", "PMC5725398", "29230567"]}, {"Citation": "Cragg G.M., Pezzuto J.M. Natural Products as a Vital Source for the Discovery of Cancer Chemotherapeutic and Chemopreventive Agents. Med. Princ. Pract. Int. J. Kuwait Univ. Health Sci. Cent. 2016;25(Suppl. S2):41\u201359. doi: 10.1159/000443404.", "ArticleIdList": ["10.1159/000443404", "PMC5588531", "26679767"]}, {"Citation": "Nwodo J.N., Ibezim A., Simoben C.V., Ntie-Kang F. Exploring Cancer Therapeutics with Natural Products from African Medicinal Plants, Part II: Alkaloids, Terpenoids and Flavonoids. Anticancer Agents Med. Chem. 2016;16:108\u2013127. doi: 10.2174/1871520615666150520143827.", "ArticleIdList": ["10.2174/1871520615666150520143827", "25991425"]}, {"Citation": "Tapiero H., Tew K.D., Ba G.N., Math\u00e9 G. Polyphenols: Do they play a role in the prevention of human pathologies? Biomed. Pharm. 2002;56:200\u2013207. doi: 10.1016/S0753-3322(02)00178-6.", "ArticleIdList": ["10.1016/S0753-3322(02)00178-6", "12109813"]}, {"Citation": "Sak K. Cytotoxicity of dietary flavonoids on different human cancer types. Pharmacogn. Rev. 2014;8:122\u2013146. doi: 10.4103/0973-7847.134247.", "ArticleIdList": ["10.4103/0973-7847.134247", "PMC4127821", "25125885"]}, {"Citation": "Huang M., Lu J.J., Huang M.Q., Bao J.L., Chen X.P., Wang Y.T. Terpenoids: Natural products for cancer therapy. Expert Opin. Investig. Drugs. 2012;21:1801\u20131818. doi: 10.1517/13543784.2012.727395.", "ArticleIdList": ["10.1517/13543784.2012.727395", "23092199"]}, {"Citation": "Amawi H., Ashby C.R., Jr., Tiwari A.K. Cancer chemoprevention through dietary flavonoids: What\u2019s limiting? Chin. J. Cancer. 2017;36:50. doi: 10.1186/s40880-017-0217-4.", "ArticleIdList": ["10.1186/s40880-017-0217-4", "PMC5477375", "28629389"]}, {"Citation": "Kumar V., Bhatt P.C., Rahman M., Kaithwas G., Choudhry H., Al-Abbasi F.A., Anwar F., Verma A. Fabrication, optimization, and characterization of umbelliferone \u03b2-D-galactopyranoside-loaded PLGA nanoparticles in treatment of hepatocellular carcinoma: In vitro and in vivo studies. Int. J. Nanomed. 2017;12:6747\u20136758. doi: 10.2147/IJN.S136629.", "ArticleIdList": ["10.2147/IJN.S136629", "PMC5600267", "28932118"]}, {"Citation": "Seca A.M.L., Pinto D. Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application. Int. J. Mol. Sci. 2018;19:263. doi: 10.3390/ijms19010263.", "ArticleIdList": ["10.3390/ijms19010263", "PMC5796209", "29337925"]}, {"Citation": "Rajesh E., Sankari L.S., Malathi L., Krupaa J.R. Naturally occurring products in cancer therapy. J. Pharm. Bioallied. Sci. 2015;7:S181\u2013S183. doi: 10.4103/0975-7406.155895.", "ArticleIdList": ["10.4103/0975-7406.155895", "PMC4439664", "26015704"]}, {"Citation": "Demain A.L., Vaishnav P. Natural products for cancer chemotherapy. Microb. Biotechnol. 2011;4:687\u2013699. doi: 10.1111/j.1751-7915.2010.00221.x.", "ArticleIdList": ["10.1111/j.1751-7915.2010.00221.x", "PMC3815406", "21375717"]}, {"Citation": "Reddy L., Odhav B., Bhoola K.D. Natural products for cancer prevention: A global perspective. Pharmacol. Ther. 2003;99:1\u201313. doi: 10.1016/S0163-7258(03)00042-1.", "ArticleIdList": ["10.1016/S0163-7258(03)00042-1", "12804695"]}, {"Citation": "Zubair H., Azim S., Ahmad A., Khan M.A., Patel G.K., Singh S., Singh A.P. Cancer Chemoprevention by Phytochemicals: Nature\u2019s Healing Touch. Molecules. 2017;22:395. doi: 10.3390/molecules22030395.", "ArticleIdList": ["10.3390/molecules22030395", "PMC6155418", "28273819"]}, {"Citation": "Burnett J., Newman B., Sun D. Targeting cancer stem cells with natural products. Curr. Drug Targets. 2012;13:1054\u20131064. doi: 10.2174/138945012802009062.", "ArticleIdList": ["10.2174/138945012802009062", "22594473"]}, {"Citation": "Kashyap D., Tuli H.S., Yerer M.B., Sharma A., Sak K., Srivastava S., Pandey A., Garg V.K., Sethi G., Bishayee A. Natural product-based nanoformulations for cancer therapy: Opportunities and challenges. Semin. Cancer Biol. 2019 doi: 10.1016/j.semcancer.2019.08.014.", "ArticleIdList": ["10.1016/j.semcancer.2019.08.014", "31421264"]}, {"Citation": "Kashyap D., Sharma A., Tuli H.S., Sak K., Punia S., Mukherjee T.K. Kaempferol\u2014A dietary anticancer molecule with multiple mechanisms of action: Recent trends and advancements. J. Funct. Foods. 2017;30:203\u2013219. doi: 10.1016/j.jff.2017.01.022.", "ArticleIdList": ["10.1016/j.jff.2017.01.022", "PMC7104980", "32288791"]}, {"Citation": "Harborne J.B. Chemicals from Plants. World Scientific/Imperial College Press; Singapore: 1999. Classes and functions of secondary products from plants; pp. 1\u201325."}, {"Citation": "Rahman M., Ahmad M.Z., Kazmi I., Akhter S., Afzal M., Gupta G., Sinha V.R. Emergence of nanomedicine as cancer targeted magic bullets: Recent development and need to address the toxicity apprehension. Curr. Drug Discov. Technol. 2012;9:319\u2013329. doi: 10.2174/157016312803305898.", "ArticleIdList": ["10.2174/157016312803305898", "22725687"]}, {"Citation": "Rahman M., Ahmad M.Z., Kazmi I., Akhter S., Afzal M., Gupta G., Jalees Ahmed F., Anwar F. Advancement in multifunctional nanoparticles for the effective treatment of cancer. Expert Opin. Drug Deliv. 2012;9:367\u2013381. doi: 10.1517/17425247.2012.668522.", "ArticleIdList": ["10.1517/17425247.2012.668522", "22400808"]}, {"Citation": "Bobo D., Robinson K.J., Islam J., Thurecht K.J., Corrie S.R. Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date. Pharm. Res. 2016;33:2373\u20132387. doi: 10.1007/s11095-016-1958-5.", "ArticleIdList": ["10.1007/s11095-016-1958-5", "27299311"]}, {"Citation": "Leonarduzzi G., Testa G., Sottero B., Gamba P., Poli G. Design and development of nanovehicle-based delivery systems for preventive or therapeutic supplementation with flavonoids. Curr. Med. Chem. 2010;17:74\u201395. doi: 10.2174/092986710789957760.", "ArticleIdList": ["10.2174/092986710789957760", "19941477"]}, {"Citation": "Jeetah R., Bhaw-Luximon A., Jhurry D. Nanopharmaceutics: Phytochemical-based controlled or sustained drug-delivery systems for cancer treatment. J. Biomed. Nanotechnol. 2014;10:1810\u20131840. doi: 10.1166/jbn.2014.1884.", "ArticleIdList": ["10.1166/jbn.2014.1884", "25992442"]}, {"Citation": "Gohulkumar M., Gurushankar K., Rajendra Prasad N., Krishnakumar N. Enhanced cytotoxicity and apoptosis-induced anticancer effect of silibinin-loaded nanoparticles in oral carcinoma (KB) cells. Mater. Sci. Eng. C Mater. Biol. Appl. 2014;41:274\u2013282. doi: 10.1016/j.msec.2014.04.056.", "ArticleIdList": ["10.1016/j.msec.2014.04.056", "24907761"]}, {"Citation": "Khan N., Bharali D.J., Adhami V.M., Siddiqui I.A., Cui H., Shabana S.M., Mousa S.A., Mukhtar H. Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model. Carcinogenesis. 2014;35:415\u2013423. doi: 10.1093/carcin/bgt321.", "ArticleIdList": ["10.1093/carcin/bgt321", "PMC3908746", "24072771"]}, {"Citation": "Majumdar D., Jung K.-H., Zhang H., Nannapaneni S., Wang X., Amin A.R.M.R., Chen Z., Chen Z.G., Shin D.M. Luteolin nanoparticle in chemoprevention: In vitro and in vivo anticancer activity. Cancer Prev. Res. 2014;7:65\u201373. doi: 10.1158/1940-6207.CAPR-13-0230.", "ArticleIdList": ["10.1158/1940-6207.CAPR-13-0230", "PMC3888883", "24403290"]}, {"Citation": "El-Far A.H., Al Jaouni S.K., Li W., Mousa S.A. Protective Roles of Thymoquinone Nanoformulations: Potential Nanonutraceuticals in Human Diseases. Nutrients. 2018;10:1369. doi: 10.3390/nu10101369.", "ArticleIdList": ["10.3390/nu10101369", "PMC6213571", "30257423"]}, {"Citation": "Ballout F., Habli Z., Rahal O.N., Fatfat M., Gali-Muhtasib H. Thymoquinone-based nanotechnology for cancer therapy: Promises and challenges. Drug Discov. Today. 2018;23:1089\u20131098. doi: 10.1016/j.drudis.2018.01.043.", "ArticleIdList": ["10.1016/j.drudis.2018.01.043", "29374534"]}, {"Citation": "Hazra B., Kumar B., Biswas S., Pandey B.N., Mishra K.P. Enhancement of the tumour inhibitory activity, in vivo, of diospyrin, a plant-derived quinonoid, through liposomal encapsulation. Toxicol. Lett. 2005;157:109\u2013117. doi: 10.1016/j.toxlet.2005.01.016.", "ArticleIdList": ["10.1016/j.toxlet.2005.01.016", "15836998"]}, {"Citation": "Anand P., Sundaram C., Jhurani S., Kunnumakkara A.B., Aggarwal B.B. Curcumin and cancer: An \u201cold-age\u201d disease with an \u201cage-old\u201d solution. Cancer Lett. 2008;267:133\u2013164. doi: 10.1016/j.canlet.2008.03.025.", "ArticleIdList": ["10.1016/j.canlet.2008.03.025", "18462866"]}, {"Citation": "Nirmala C., Puvanakrishnan R. Protective role of curcumin against isoproterenol induced myocardial infarction in rats. Mol. Cell. Biochem. 1996;159:85\u201393. doi: 10.1007/BF00420910.", "ArticleIdList": ["10.1007/BF00420910", "8858558"]}, {"Citation": "Jordan W.C., Drew C.R. Curcumin\u2014A natural herb with anti-HIV activity. J. Natl. Med. Assoc. 1996;88:333.", "ArticleIdList": ["PMC2608099", "8691490"]}, {"Citation": "Phan T.T., See P., Lee S.T., Chan S.Y. Protective effects of curcumin against oxidative damage on skin cells in vitro: Its implication for wound healing. J. Trauma. 2001;51:927\u2013931. doi: 10.1097/00005373-200111000-00017.", "ArticleIdList": ["10.1097/00005373-200111000-00017", "11706342"]}, {"Citation": "Lim G.P., Chu T., Yang F., Beech W., Frautschy S.A., Cole G.M. The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse. J. Neurosci. 2001;21:8370. doi: 10.1523/JNEUROSCI.21-21-08370.2001.", "ArticleIdList": ["10.1523/JNEUROSCI.21-21-08370.2001", "PMC6762797", "11606625"]}, {"Citation": "Gupta S.C., Patchva S., Koh W., Aggarwal B.B. Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin. Exp. Pharmacol. Physiol. 2012;39:283\u2013299. doi: 10.1111/j.1440-1681.2011.05648.x.", "ArticleIdList": ["10.1111/j.1440-1681.2011.05648.x", "PMC3288651", "22118895"]}, {"Citation": "Arablou T., Kolahdouz-Mohammadi R. Curcumin and endometriosis: Review on potential roles and molecular mechanisms. Biomed. Pharm. 2018;97:91\u201397. doi: 10.1016/j.biopha.2017.10.119.", "ArticleIdList": ["10.1016/j.biopha.2017.10.119", "29080464"]}, {"Citation": "Ak T., G\u00fcl\u00e7in \u0130. Antioxidant and radical scavenging properties of curcumin. Chem. Biol. Interact. 2008;174:27\u201337. doi: 10.1016/j.cbi.2008.05.003.", "ArticleIdList": ["10.1016/j.cbi.2008.05.003", "18547552"]}, {"Citation": "Sharma O.P. Antioxidant activity of curcumin and related compounds. Biochem. Pharm. 1976;25:1811\u20131812. doi: 10.1016/0006-2952(76)90421-4.", "ArticleIdList": ["10.1016/0006-2952(76)90421-4", "942483"]}, {"Citation": "Bhattacharyya S., Mandal D., Sen G.S., Pal S., Banerjee S., Lahiry L., Finke J.H., Tannenbaum C.S., Das T., Sa G. Tumor-induced oxidative stress perturbs nuclear factor-kappaB activity-augmenting tumor necrosis factor-alpha-mediated T-cell death: Protection by curcumin. Cancer Res. 2007;67:362\u2013370. doi: 10.1158/0008-5472.CAN-06-2583.", "ArticleIdList": ["10.1158/0008-5472.CAN-06-2583", "17210719"]}, {"Citation": "Sandur S.K., Pandey M.K., Sung B., Ahn K.S., Murakami A., Sethi G., Limtrakul P., Badmaev V., Aggarwal B.B. Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis. 2007;28:1765\u20131773. doi: 10.1093/carcin/bgm123.", "ArticleIdList": ["10.1093/carcin/bgm123", "17522064"]}, {"Citation": "De R., Kundu P., Swarnakar S., Ramamurthy T., Chowdhury A., Nair G.B., Mukhopadhyay A.K. Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrob. Agents Chemother. 2009;53:1592\u20131597. doi: 10.1128/AAC.01242-08.", "ArticleIdList": ["10.1128/AAC.01242-08", "PMC2663130", "19204190"]}, {"Citation": "Mun S.H., Joung D.K., Kim Y.S., Kang O.H., Kim S.B., Seo Y.S., Kim Y.C., Lee D.S., Shin D.W., Kweon K.T., et al. Synergistic antibacterial effect of curcumin against methicillin-resistant Staphylococcus aureus. Phytomedicine. 2013;20:714\u2013718. doi: 10.1016/j.phymed.2013.02.006.", "ArticleIdList": ["10.1016/j.phymed.2013.02.006", "23537748"]}, {"Citation": "Neelofar K., Shreaz S., Rimple B., Muralidhar S., Nikhat M., Khan L.A. Curcumin as a promising anticandidal of clinical interest. Can. J. Microbiol. 2011;57:204\u2013210. doi: 10.1139/W10-117.", "ArticleIdList": ["10.1139/W10-117", "21358761"]}, {"Citation": "Khalil O.A.K., de Faria Oliveira O.M.M., Vellosa J.C.R., de Quadros A.U., Dalposso L.M., Karam T.K., Mainardes R.M., Khalil N.M. Curcumin antifungal and antioxidant activities are increased in the presence of ascorbic acid. Food Chem. 2012;133:1001\u20131005. doi: 10.1016/j.foodchem.2012.02.009.", "ArticleIdList": ["10.1016/j.foodchem.2012.02.009"]}, {"Citation": "Tomeh M.A., Hadianamrei R., Zhao X. A Review of Curcumin and Its Derivatives as Anticancer Agents. Int. J. Mol. Sci. 2019;20:1033. doi: 10.3390/ijms20051033.", "ArticleIdList": ["10.3390/ijms20051033", "PMC6429287", "30818786"]}, {"Citation": "Chen J., He Z.M., Wang F.L., Zhang Z.S., Liu X.Z., Zhai D.D., Chen W.D. Curcumin and its promise as an anticancer drug: An analysis of its anticancer and antifungal effects in cancer and associated complications from invasive fungal infections. Eur. J. Pharm. 2016;772:33\u201342. doi: 10.1016/j.ejphar.2015.12.038.", "ArticleIdList": ["10.1016/j.ejphar.2015.12.038", "26723514"]}, {"Citation": "Ravindranath V., Chandrasekhara N. Absorption and tissue distribution of curcumin in rats. Toxicology. 1980;16:259\u2013265. doi: 10.1016/0300-483X(80)90122-5.", "ArticleIdList": ["10.1016/0300-483X(80)90122-5", "7423534"]}, {"Citation": "Ravindranath V., Chandrasekhara N. In vitro studies on the intestinal absorption of curcumin in rats. Toxicology. 1981;20:251\u2013257. doi: 10.1016/0300-483X(81)90056-1.", "ArticleIdList": ["10.1016/0300-483X(81)90056-1", "7256789"]}, {"Citation": "Ravindranath V., Chandrasekhara N. Metabolism of curcumn-studies with [3H]curcumin. Toxicology. 1981;22:337\u2013344. doi: 10.1016/0300-483X(81)90027-5.", "ArticleIdList": ["10.1016/0300-483X(81)90027-5", "7342372"]}, {"Citation": "Gupta N.K., Dixit V.K. Bioavailability Enhancement of Curcumin by Complexation with Phosphatidyl Choline. J. Pharm. Sci. 2011;100:1987\u20131995. doi: 10.1002/jps.22393.", "ArticleIdList": ["10.1002/jps.22393", "21374628"]}, {"Citation": "Bollu V.S., Barui A.K., Mondal S.K., Prashar S., Fajardo M., Briones D., Rodr\u00edguez-Di\u00e9guez A., Patra C.R., G\u00f3mez-Ruiz S. Curcumin-loaded silica-based mesoporous materials: Synthesis, characterization and cytotoxic properties against cancer cells. Mater. Sci. Eng. C. 2016;63:393\u2013410. doi: 10.1016/j.msec.2016.03.011.", "ArticleIdList": ["10.1016/j.msec.2016.03.011", "27040234"]}, {"Citation": "Datz S., Engelke H., Schirnding C.V., Nguyen L., Bein T. Lipid bilayer-coated curcumin-based mesoporous organosilica nanoparticles for cellular delivery. Microporous Mesoporous Mater. 2016;225:371\u2013377. doi: 10.1016/j.micromeso.2015.12.006.", "ArticleIdList": ["10.1016/j.micromeso.2015.12.006"]}, {"Citation": "Rahmatolahzadeh R., Hamadanian M., Ma\u2019mani L., Shafiee A. Aspartic acid functionalized PEGylated MSN@GO hybrid as an effective and sustainable nano-system for in-vitro drug delivery. Adv. Med. Sci. 2018;63:257\u2013264. doi: 10.1016/j.advms.2018.01.003.", "ArticleIdList": ["10.1016/j.advms.2018.01.003", "29486375"]}, {"Citation": "Song Y., Cai L., Tian Z., Wu Y., Chen J. Phytochemical Curcumin-Coformulated, Silver-Decorated Melanin-like Polydopamine/Mesoporous Silica Composites with Improved Antibacterial and Chemotherapeutic Effects against Drug-Resistant Cancer Cells. ACS Omega. 2020;5:15083\u201315094. doi: 10.1021/acsomega.0c00912.", "ArticleIdList": ["10.1021/acsomega.0c00912", "PMC7330891", "32637781"]}, {"Citation": "Gao J., Fan K., Jin Y., Zhao L., Wang Q., Tang Y., Xu H., Liu Z., Wang S., Lin J., et al. PEGylated lipid bilayer coated mesoporous silica nanoparticles co-delivery of paclitaxel and curcumin leads to increased tumor site drug accumulation and reduced tumor burden. Eur. J. Pharm. Sci. 2019;140:105070. doi: 10.1016/j.ejps.2019.105070.", "ArticleIdList": ["10.1016/j.ejps.2019.105070", "31518679"]}, {"Citation": "Sun X., Wang N., Yang L.-Y., Ouyang X.-K., Huang F. Folic Acid and PEI Modified Mesoporous Silica for Targeted Delivery of Curcumin. Pharmaceutics. 2019;11:430. doi: 10.3390/pharmaceutics11090430.", "ArticleIdList": ["10.3390/pharmaceutics11090430", "PMC6781278", "31450762"]}, {"Citation": "Mashayekhi S., Rasoulpoor S., Shabani S., Esmaeilizadeh N., Serati-Nouri H., Sheervalilou R., Pilehvar-Soltanahmadi Y. Curcumin-loaded mesoporous silica nanoparticles/nanofiber composites for supporting long-term proliferation and stemness preservation of adipose-derived stem cells. Int. J. Pharm. 2020;587:119656. doi: 10.1016/j.ijpharm.2020.119656.", "ArticleIdList": ["10.1016/j.ijpharm.2020.119656", "32687972"]}, {"Citation": "He Y., Shao L., Usman I., Hu Y., Pan A., Liang S., Xu H. A pH-responsive dissociable mesoporous silica-based nanoplatform enabling efficient dual-drug co-delivery and rapid clearance for cancer therapy. Biomater. Sci. 2020;8:3418\u20133429. doi: 10.1039/D0BM00204F.", "ArticleIdList": ["10.1039/D0BM00204F", "32405634"]}, {"Citation": "Wibowo F.R., Saputra O.A., Lestari W.W., Koketsu M., Mukti R.R., Martien R. pH-Triggered Drug Release Controlled by Poly(Styrene Sulfonate) Growth Hollow Mesoporous Silica Nanoparticles. ACS Omega. 2020;5:4261\u20134269. doi: 10.1021/acsomega.9b04167.", "ArticleIdList": ["10.1021/acsomega.9b04167", "PMC7057687", "32149256"]}, {"Citation": "Kong Z.L., Kuo H.P., Johnson A., Wu L.C., Chang K.L.B. Curcumin-Loaded Mesoporous Silica Nanoparticles Markedly Enhanced Cytotoxicity in Hepatocellular Carcinoma Cells. Int. J. Mol. Sci. 2019;20:2918. doi: 10.3390/ijms20122918.", "ArticleIdList": ["10.3390/ijms20122918", "PMC6628080", "31207976"]}, {"Citation": "Harini L., Srivastava S., Gnanakumar G.P., Karthikeyan B., Ross C., Krishnakumar V., Kannan V.R., Sundar K., Kathiresan T. An ingenious non-spherical mesoporous silica nanoparticle cargo with curcumin induces mitochondria-mediated apoptosis in breast cancer (MCF-7) cells. Oncotarget. 2019;10:1193\u20131208. doi: 10.18632/oncotarget.26623.", "ArticleIdList": ["10.18632/oncotarget.26623", "PMC6383822", "30838091"]}, {"Citation": "Chen C., Sun W., Wang X., Wang Y., Wang P. Rational design of curcumin loaded multifunctional mesoporous silica nanoparticles to enhance the cytotoxicity for targeted and controlled drug release. Mater. Sci. Eng. C. 2018;85:88\u201396. doi: 10.1016/j.msec.2017.12.007.", "ArticleIdList": ["10.1016/j.msec.2017.12.007", "29407161"]}, {"Citation": "Lv Y., Li J., Chen H., Bai Y., Zhang L. Glycyrrhetinic acid-functionalized mesoporous silica nanoparticles as hepatocellular carcinoma-targeted drug carrier. Int. J. Nanomed. 2017;12:4361\u20134370. doi: 10.2147/IJN.S135626.", "ArticleIdList": ["10.2147/IJN.S135626", "PMC5476610", "28652738"]}, {"Citation": "Harini L., Karthikeyan B., Srivastava S., Suresh S.B., Ross C., Gnanakumar G., Rajagopal S., Sundar K., Kathiresan T. Polyethylenimine-modified curcumin-loaded mesoporus silica nanoparticle (MCM-41) induces cell death in MCF-7 cell line. IET Nanobiotechnol. 2017;11:57\u201361. doi: 10.1049/iet-nbt.2016.0075.", "ArticleIdList": ["10.1049/iet-nbt.2016.0075", "PMC8676348", "28476962"]}, {"Citation": "Tiwari N., Nawale L., Sarkar D., Badiger M.V. Carboxymethyl Cellulose-Grafted Mesoporous Silica Hybrid Nanogels for Enhanced Cellular Uptake and Release of Curcumin. Gels. 2017;3:8. doi: 10.3390/gels3010008.", "ArticleIdList": ["10.3390/gels3010008", "PMC6318674", "30920505"]}, {"Citation": "Wang J., Wang Y., Liu Q., Yang L., Zhu R., Yu C., Wang S. Rational Design of Multifunctional Dendritic Mesoporous Silica Nanoparticles to Load Curcumin and Enhance Efficacy for Breast Cancer Therapy. ACS Appl. Mater. Interfaces. 2016;8:26511\u201326523. doi: 10.1021/acsami.6b08400.", "ArticleIdList": ["10.1021/acsami.6b08400", "27619078"]}, {"Citation": "Kotcherlakota R., Barui A.K., Prashar S., Fajardo M., Briones D., Rodr\u00edguez-Di\u00e9guez A., Patra C.R., G\u00f3mez-Ruiz S. Curcumin loaded mesoporous silica: An effective drug delivery system for cancer treatment. Biomater. Sci. 2016;4:448\u2013459. doi: 10.1039/C5BM00552C.", "ArticleIdList": ["10.1039/C5BM00552C", "26674254"]}, {"Citation": "Li Y., Yao J., Han C., Yang J., Chaudhry M.T., Wang S., Liu H., Yin Y. Quercetin, Inflammation and Immunity. Nutrients. 2016;8:167. doi: 10.3390/nu8030167.", "ArticleIdList": ["10.3390/nu8030167", "PMC4808895", "26999194"]}, {"Citation": "Davis J.M., Murphy E.A., Carmichael M.D. Effects of the dietary flavonoid quercetin upon performance and health. Curr. Sports Med. Rep. 2009;8:206\u2013213. doi: 10.1249/JSR.0b013e3181ae8959.", "ArticleIdList": ["10.1249/JSR.0b013e3181ae8959", "19584608"]}, {"Citation": "Lamson D.W., Brignall M.S. Antioxidants and cancer, part 3: Quercetin. Altern. Med. Rev. 2000;5:196\u2013208.", "ArticleIdList": ["10869101"]}, {"Citation": "Boots A.W., Haenen G.R., Bast A. Health effects of quercetin: From antioxidant to nutraceutical. Eur. J. Pharm. 2008;585:325\u2013337. doi: 10.1016/j.ejphar.2008.03.008.", "ArticleIdList": ["10.1016/j.ejphar.2008.03.008", "18417116"]}, {"Citation": "Choi H.J., Song J.H., Park K.S., Kwon D.H. Inhibitory effects of quercetin 3-rhamnoside on influenza A virus replication. Eur. J. Pharm. Sci. 2009;37:329\u2013333. doi: 10.1016/j.ejps.2009.03.002.", "ArticleIdList": ["10.1016/j.ejps.2009.03.002", "19491023"]}, {"Citation": "Rotelli A.E., Guardia T., Ju\u00e1rez A.O., de la Rocha N.E., Pelzer L.E. Comparative study of flavonoids in experimental models of inflammation. Pharm. Res. 2003;48:601\u2013606. doi: 10.1016/S1043-6618(03)00225-1.", "ArticleIdList": ["10.1016/S1043-6618(03)00225-1", "14527825"]}, {"Citation": "Kumar B., Gupta S.K., Nag T.C., Srivastava S., Saxena R., Jha K.A., Srinivasan B.P. Retinal neuroprotective effects of quercetin in streptozotocin-induced diabetic rats. Exp. Eye Res. 2014;125:193\u2013202. doi: 10.1016/j.exer.2014.06.009.", "ArticleIdList": ["10.1016/j.exer.2014.06.009", "24952278"]}, {"Citation": "Hu X.T., Ding C., Zhou N., Xu C. Quercetin protects gastric epithelial cell from oxidative damage in vitro and in vivo. Eur. J. Pharm. 2015;754:115\u2013124. doi: 10.1016/j.ejphar.2015.02.007.", "ArticleIdList": ["10.1016/j.ejphar.2015.02.007", "25701726"]}, {"Citation": "Aguirre L., Arias N., Teresa Macarulla M., Gracia A., Portillo M.P. Beneficial effects of quercetin on obesity and diabetes. Open Nutraceuticals J. 2011;4:189\u2013198."}, {"Citation": "Yang L., Hu Z., Zhu J., Liang Q., Zhou H., Li J., Fan X., Zhao Z., Pan H., Fei B. Systematic Elucidation of the Mechanism of Quercetin against Gastric Cancer via Network Pharmacology Approach. BioMed Res. Int. 2020;2020:3860213. doi: 10.1155/2020/3860213.", "ArticleIdList": ["10.1155/2020/3860213", "PMC7486643", "32964029"]}, {"Citation": "Xu D., Hu M.J., Wang Y.Q., Cui Y.L. Antioxidant Activities of Quercetin and Its Complexes for Medicinal Application. Molecules. 2019;24:1123. doi: 10.3390/molecules24061123.", "ArticleIdList": ["10.3390/molecules24061123", "PMC6470739", "30901869"]}, {"Citation": "Rauf A., Imran M., Khan I.A., Ur-Rehman M., Gilani S.A., Mehmood Z., Mubarak M.S. Anticancer potential of quercetin: A comprehensive review. Phytother. Res. 2018;32:2109\u20132130. doi: 10.1002/ptr.6155.", "ArticleIdList": ["10.1002/ptr.6155", "30039547"]}, {"Citation": "Chun O.K., Chung S.J., Song W.O. Estimated dietary flavonoid intake and major food sources of U.S. adults. J. Nutr. 2007;137:1244\u20131252. doi: 10.1093/jn/137.5.1244.", "ArticleIdList": ["10.1093/jn/137.5.1244", "17449588"]}, {"Citation": "Gugler R., Leschik M., Dengler H.J. Disposition of quercetin in man after single oral and intravenous doses. Eur. J. Clin. Pharm. 1975;9:229\u2013234. doi: 10.1007/BF00614022.", "ArticleIdList": ["10.1007/BF00614022", "1233267"]}, {"Citation": "Egert S., Wolffram S., Bosy-Westphal A., Boesch-Saadatmandi C., Wagner A.E., Frank J., Rimbach G., Mueller M.J. Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. J. Nutr. 2008;138:1615\u20131621. doi: 10.1093/jn/138.9.1615.", "ArticleIdList": ["10.1093/jn/138.9.1615", "18716159"]}, {"Citation": "Thangasamy T., Sittadjody S., Burd R. Complementary and Alternative Therapies and the Aging Population. Elsevier; Amsterdam, The Netherlands: 2009. Quercetin: A potential complementary and alternative cancer therapy; pp. 563\u2013584."}, {"Citation": "Novo M.C., Osugui L., dos Reis V.O., Longo-Maug\u00e9ri I.M., Mariano M., Popi A.F. Blockage of Wnt/\u03b2-catenin signaling by quercetin reduces survival and proliferation of B-1 cells in vitro. Immunobiology. 2015;220:60\u201367. doi: 10.1016/j.imbio.2014.09.001.", "ArticleIdList": ["10.1016/j.imbio.2014.09.001", "25245014"]}, {"Citation": "Sharmila G., Bhat F.A., Arunkumar R., Elumalai P., Raja Singh P., Senthilkumar K., Arunakaran J. Chemopreventive effect of quercetin, a natural dietary flavonoid on prostate cancer in in vivo model. Clin. Nutr. 2014;33:718\u2013726. doi: 10.1016/j.clnu.2013.08.011.", "ArticleIdList": ["10.1016/j.clnu.2013.08.011", "24080313"]}, {"Citation": "Vafadar A., Shabaninejad Z., Movahedpour A., Fallahi F., Taghavipour M., Ghasemi Y., Akbari M., Shafiee A., Hajighadimi S., Moradizarmehri S., et al. Quercetin and cancer: New insights into its therapeutic effects on ovarian cancer cells. Cell. Biosci. 2020;10:32. doi: 10.1186/s13578-020-00397-0.", "ArticleIdList": ["10.1186/s13578-020-00397-0", "PMC7063794", "32175075"]}, {"Citation": "Fern\u00e1ndez-Palanca P., Fondevila F., M\u00e9ndez-Blanco C., Tu\u00f1\u00f3n M.J., Gonz\u00e1lez-Gallego J., Mauriz J.L. Antitumor Effects of Quercetin in Hepatocarcinoma In Vitro and In Vivo Models: A Systematic Review. Nutrients. 2019;11:2875. doi: 10.3390/nu11122875.", "ArticleIdList": ["10.3390/nu11122875", "PMC6950472", "31775362"]}, {"Citation": "Jana N., B\u0159etislav G., Pavel S., Pavla U. Potential of the Flavonoid Quercetin to Prevent and Treat Cancer\u2014Current Status of Research. Klin. Onkol. 2018;31:184\u2013190. doi: 10.14735/amko2018184.", "ArticleIdList": ["10.14735/amko2018184", "30441971"]}, {"Citation": "Ward A.B., Mir H., Kapur N., Gales D.N., Carriere P.P., Singh S. Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic pathways. World J. Surg. Oncol. 2018;16:108. doi: 10.1186/s12957-018-1400-z.", "ArticleIdList": ["10.1186/s12957-018-1400-z", "PMC6001031", "29898731"]}, {"Citation": "Tang S.M., Deng X.T., Zhou J., Li Q.P., Ge X.X., Miao L. Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects. Biomed. Pharm. 2020;121:109604. doi: 10.1016/j.biopha.2019.109604.", "ArticleIdList": ["10.1016/j.biopha.2019.109604", "31733570"]}, {"Citation": "Murakami A., Ashida H., Terao J. Multitargeted cancer prevention by quercetin. Cancer Lett. 2008;269:315\u2013325. doi: 10.1016/j.canlet.2008.03.046.", "ArticleIdList": ["10.1016/j.canlet.2008.03.046", "18467024"]}, {"Citation": "Cai X., Fang Z., Dou J., Yu A., Zhai G. Bioavailability of quercetin: Problems and promises. Curr. Med. Chem. 2013;20:2572\u20132582. doi: 10.2174/09298673113209990120.", "ArticleIdList": ["10.2174/09298673113209990120", "23514412"]}, {"Citation": "Niazvand F., Orazizadeh M., Khorsandi L., Abbaspour M., Mansouri E., Khodadadi A. Effects of Quercetin-Loaded Nanoparticles on MCF-7 Human Breast Cancer Cells. Medicina. 2019;55:114. doi: 10.3390/medicina55040114.", "ArticleIdList": ["10.3390/medicina55040114", "PMC6524048", "31013662"]}, {"Citation": "Nam J.-S., Sharma A.R., Nguyen L.T., Chakraborty C., Sharma G., Lee S.-S. Application of Bioactive Quercetin in Oncotherapy: From Nutrition to Nanomedicine. Molecules. 2016;21:108. doi: 10.3390/molecules21010108.", "ArticleIdList": ["10.3390/molecules21010108", "PMC6273093", "26797598"]}, {"Citation": "Baksi R., Singh D.P., Borse S.P., Rana R., Sharma V., Nivsarkar M. In vitro and in vivo anticancer efficacy potential of Quercetin loaded polymeric nanoparticles. Biomed. Pharmacother. 2018;106:1513\u20131526. doi: 10.1016/j.biopha.2018.07.106.", "ArticleIdList": ["10.1016/j.biopha.2018.07.106", "30119227"]}, {"Citation": "Lou M., Zhang L.-N., Ji P.-G., Feng F.-Q., Liu J.-H., Yang C., Li B.-F., Wang L. Quercetin nanoparticles induced autophagy and apoptosis through AKT/ERK/Caspase-3 signaling pathway in human neuroglioma cells: In vitro and in vivo. Biomed. Pharmacother. 2016;84:1\u20139. doi: 10.1016/j.biopha.2016.08.055.", "ArticleIdList": ["10.1016/j.biopha.2016.08.055", "27621033"]}, {"Citation": "Rajesh Kumar S., Priyatharshni S., Babu V.N., Mangalaraj D., Viswanathan C., Kannan S., Ponpandian N. Quercetin conjugated superparamagnetic magnetite nanoparticles for in-vitro analysis of breast cancer cell lines for chemotherapy applications. J. Colloid Interface Sci. 2014;436:234\u2013242. doi: 10.1016/j.jcis.2014.08.064.", "ArticleIdList": ["10.1016/j.jcis.2014.08.064", "25278361"]}, {"Citation": "Ren K.-W., Li Y.-H., Wu G., Ren J.-Z., Lu H.-B., Li Z.-M., Han X.-W. Quercetin nanoparticles display antitumor activity via proliferation inhibition and apoptosis induction in liver cancer cells. Int. J. Oncol. 2017;50:1299\u20131311. doi: 10.3892/ijo.2017.3886.", "ArticleIdList": ["10.3892/ijo.2017.3886", "28259895"]}, {"Citation": "Xu G., Li B., Wang T., Wan J., Zhang Y., Huang J., Shen Y. Enhancing the anti-ovarian cancer activity of quercetin using a self-assembling micelle and thermosensitive hydrogel drug delivery system. RSC Adv. 2018;8:21229\u201321242. doi: 10.1039/C8RA03274B.", "ArticleIdList": ["10.1039/C8RA03274B", "PMC9080896", "35539921"]}, {"Citation": "Liu M., Fu M., Yang X., Jia G., Shi X., Ji J., Liu X., Zhai G. Paclitaxel and quercetin co-loaded functional mesoporous silica nanoparticles overcoming multidrug resistance in breast cancer. Colloids Surf. B Biointerfaces. 2020;196:111284. doi: 10.1016/j.colsurfb.2020.111284.", "ArticleIdList": ["10.1016/j.colsurfb.2020.111284", "32771817"]}, {"Citation": "Huang C., Chen T., Zhu D., Huang Q. Enhanced Tumor Targeting and Radiotherapy by Quercetin Loaded Biomimetic Nanoparticles. Front. Chem. 2020;8:225. doi: 10.3389/fchem.2020.00225.", "ArticleIdList": ["10.3389/fchem.2020.00225", "PMC7136572", "32296682"]}, {"Citation": "Shao M., Chang C., Liu Z., Chen K., Zhou Y., Zheng G., Huang Z., Xu H., Xu P., Lu B. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance. Colloids Surf. B Biointerfaces. 2019;183:110427. doi: 10.1016/j.colsurfb.2019.110427.", "ArticleIdList": ["10.1016/j.colsurfb.2019.110427", "31408782"]}, {"Citation": "Ko J.-H., Sethi G., Um J.-Y., Shanmugam M.K., Arfuso F., Kumar A.P., Bishayee A., Ahn K.S. The Role of Resveratrol in Cancer Therapy. Int. J. Mol. Sci. 2017;18:2589. doi: 10.3390/ijms18122589.", "ArticleIdList": ["10.3390/ijms18122589", "PMC5751192", "29194365"]}, {"Citation": "Shukla Y., Singh R. Resveratrol and cellular mechanisms of cancer prevention. Ann. N. Y. Acad. Sci. 2011;1215:1\u20138. doi: 10.1111/j.1749-6632.2010.05870.x.", "ArticleIdList": ["10.1111/j.1749-6632.2010.05870.x", "21261635"]}, {"Citation": "Patel K.R., Brown V.A., Jones D.J., Britton R.G., Hemingway D., Miller A.S., West K.P., Booth T.D., Perloff M., Crowell J.A., et al. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res. 2010;70:7392\u20137399. doi: 10.1158/0008-5472.CAN-10-2027.", "ArticleIdList": ["10.1158/0008-5472.CAN-10-2027", "PMC2948608", "20841478"]}, {"Citation": "Kjaer T.N., Ornstrup M.J., Poulsen M.M., J\u00f8rgensen J.O., Hougaard D.M., Cohen A.S., Neghabat S., Richelsen B., Pedersen S.B. Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4-month randomised trial in middle-aged men. Prostate. 2015;75:1255\u20131263. doi: 10.1002/pros.23006.", "ArticleIdList": ["10.1002/pros.23006", "25939591"]}, {"Citation": "Ma D.S.L., Tan L.T.-H., Chan K.-G., Yap W.H., Pusparajah P., Chuah L.-H., Ming L.C., Khan T.M., Lee L.-H., Goh B.-H. Resveratrol-Potential Antibacterial Agent against Foodborne Pathogens. Front. Pharmacol. 2018;9:102. doi: 10.3389/fphar.2018.00102.", "ArticleIdList": ["10.3389/fphar.2018.00102", "PMC5826062", "29515440"]}, {"Citation": "Perrone D., Fuggetta M.P., Ardito F., Cottarelli A., De Filippis A., Ravagnan G., De Maria S., Lo Muzio L. Resveratrol (3,5,4\u2019-trihydroxystilbene) and its properties in oral diseases. Exp. Med. 2017;14:3\u20139. doi: 10.3892/etm.2017.4472.", "ArticleIdList": ["10.3892/etm.2017.4472", "PMC5488484", "28672886"]}, {"Citation": "Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 1997;275:218\u2013220. doi: 10.1126/science.275.5297.218.", "ArticleIdList": ["10.1126/science.275.5297.218", "8985016"]}, {"Citation": "Jung C.M., Heinze T.M., Schnackenberg L.K., Mullis L.B., Elkins S.A., Elkins C.A., Steele R.S., Sutherland J.B. Interaction of dietary resveratrol with animal-associated bacteria. FEMS Microbiol. Lett. 2009;297:266\u2013273. doi: 10.1111/j.1574-6968.2009.01691.x.", "ArticleIdList": ["10.1111/j.1574-6968.2009.01691.x", "19566680"]}, {"Citation": "Fern\u00e1ndez-Mar M.I., Mateos R., Garc\u00eda-Parrilla M.C., Puertas B., Cantos-Villar E. Bioactive compounds in wine: Resveratrol, hydroxytyrosol and melatonin: A review. Food Chem. 2012;130:797\u2013813. doi: 10.1016/j.foodchem.2011.08.023.", "ArticleIdList": ["10.1016/j.foodchem.2011.08.023"]}, {"Citation": "Athar M., Back J.H., Tang X., Kim K.H., Kopelovich L., Bickers D.R., Kim A.L. Resveratrol: A review of preclinical studies for human cancer prevention. Toxicol. Appl. Pharm. 2007;224:274\u2013283. doi: 10.1016/j.taap.2006.12.025.", "ArticleIdList": ["10.1016/j.taap.2006.12.025", "PMC2083123", "17306316"]}, {"Citation": "Sawda C., Moussa C., Turner R.S. Resveratrol for Alzheimer\u2019s disease. Ann. N. Y. Acad. Sci. 2017;1403:142\u2013149. doi: 10.1111/nyas.13431.", "ArticleIdList": ["10.1111/nyas.13431", "PMC5664214", "28815614"]}, {"Citation": "G\u00fcl\u00e7in \u0130. Antioxidant properties of resveratrol: A structure\u2013activity insight. Innov. Food Sci. Emerg. Technol. 2010;11:210\u2013218. doi: 10.1016/j.ifset.2009.07.002.", "ArticleIdList": ["10.1016/j.ifset.2009.07.002"]}, {"Citation": "De S\u00e1 Coutinho D., Pacheco M.T., Frozza R.L., Bernardi A. Anti-Inflammatory Effects of Resveratrol: Mechanistic Insights. Int. J. Mol. Sci. 2018;19:1812. doi: 10.3390/ijms19061812.", "ArticleIdList": ["10.3390/ijms19061812", "PMC6032205", "29925765"]}, {"Citation": "Gao X., Xu Y.X., Janakiraman N., Chapman R.A., Gautam S.C. Immunomodulatory activity of resveratrol: Suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production. Biochem. Pharm. 2001;62:1299\u20131308. doi: 10.1016/S0006-2952(01)00775-4.", "ArticleIdList": ["10.1016/S0006-2952(01)00775-4", "11705464"]}, {"Citation": "Trung L.Q., An D.T.T. Is Resveratrol a Cancer Immunomodulatory Molecule? Front. Pharmacol. 2018;9:1255. doi: 10.3389/fphar.2018.01255.", "ArticleIdList": ["10.3389/fphar.2018.01255", "PMC6232184", "30459616"]}, {"Citation": "Berge G., \u00d8vreb\u00f8 S., Eilertsen E., Haugen A., Mollerup S. Analysis of resveratrol as a lung cancer chemopreventive agent in A/J mice exposed to benzo[a]pyrene. Br. J. Cancer. 2004;91:1380\u20131383. doi: 10.1038/sj.bjc.6602125.", "ArticleIdList": ["10.1038/sj.bjc.6602125", "PMC2409901", "15316568"]}, {"Citation": "Yu Y.H., Chen H.A., Chen P.S., Cheng Y.J., Hsu W.H., Chang Y.W., Chen Y.H., Jan Y., Hsiao M., Chang T.Y., et al. MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol. Oncogene. 2013;32:431\u2013443. doi: 10.1038/onc.2012.74.", "ArticleIdList": ["10.1038/onc.2012.74", "22410781"]}, {"Citation": "Yin H.T., Tian Q.Z., Guan L., Zhou Y., Huang X.E., Zhang H. In vitro and in vivo evaluation of the antitumor efficiency of resveratrol against lung cancer. Asian Pac. J. Cancer Prev. 2013;14:1703\u20131706. doi: 10.7314/APJCP.2013.14.3.1703.", "ArticleIdList": ["10.7314/APJCP.2013.14.3.1703", "23679260"]}, {"Citation": "Roy S.K., Chen Q., Fu J., Shankar S., Srivastava R.K. Resveratrol inhibits growth of orthotopic pancreatic tumors through activation of FOXO transcription factors. PLoS ONE. 2011;6:e25166. doi: 10.1371/journal.pone.0025166.", "ArticleIdList": ["10.1371/journal.pone.0025166", "PMC3181262", "21980390"]}, {"Citation": "Lin H.C., Chen Y.F., Hsu W.H., Yang C.W., Kao C.H., Tsai T.F. Resveratrol helps recovery from fatty liver and protects against hepatocellular carcinoma induced by hepatitis B virus X protein in a mouse model. Cancer Prev. Res. 2012;5:952\u2013962. doi: 10.1158/1940-6207.CAPR-12-0001.", "ArticleIdList": ["10.1158/1940-6207.CAPR-12-0001", "22659145"]}, {"Citation": "Carb\u00f3 N., Costelli P., Baccino F.M., L\u00f3pez-Soriano F.J., Argil\u00e9s J.M. Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model. Biochem. Biophys. Res. Commun. 1999;254:739\u2013743. doi: 10.1006/bbrc.1998.9916.", "ArticleIdList": ["10.1006/bbrc.1998.9916", "9920811"]}, {"Citation": "Chatterjee K., Mukherjee S., Vanmanen J., Banerjee P., Fata J.E. Dietary Polyphenols, Resveratrol and Pterostilbene Exhibit Antitumor Activity on an HPV E6-Positive Cervical Cancer Model: An in vitro and in vivo Analysis. Front. Oncol. 2019;9:352. doi: 10.3389/fonc.2019.00352.", "ArticleIdList": ["10.3389/fonc.2019.00352", "PMC6521745", "31143704"]}, {"Citation": "Huderson A.C., Myers J.N., Niaz M.S., Washington M.K., Ramesh A. Chemoprevention of benzo(a)pyrene-induced colon polyps in ApcMin mice by resveratrol. J. Nutr. Biochem. 2013;24:713\u2013724. doi: 10.1016/j.jnutbio.2012.04.005.", "ArticleIdList": ["10.1016/j.jnutbio.2012.04.005", "PMC3499643", "22889612"]}, {"Citation": "Wang T.T., Hudson T.S., Wang T.C., Remsberg C.M., Davies N.M., Takahashi Y., Kim Y.S., Seifried H., Vinyard B.T., Perkins S.N., et al. Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo. Carcinogenesis. 2008;29:2001\u20132010. doi: 10.1093/carcin/bgn131.", "ArticleIdList": ["10.1093/carcin/bgn131", "PMC2722852", "18586690"]}, {"Citation": "Bove K., Lincoln D.W., Tsan M.F. Effect of resveratrol on growth of 4T1 breast cancer cells in vitro and in vivo. Biochem. Biophys. Res. Commun. 2002;291:1001\u20131005. doi: 10.1006/bbrc.2002.6554.", "ArticleIdList": ["10.1006/bbrc.2002.6554", "11866465"]}, {"Citation": "Garvin S., Ollinger K., Dabrosin C. Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo. Cancer Lett. 2006;231:113\u2013122. doi: 10.1016/j.canlet.2005.01.031.", "ArticleIdList": ["10.1016/j.canlet.2005.01.031", "16356836"]}, {"Citation": "Bhat K.P., Lantvit D., Christov K., Mehta R.G., Moon R.C., Pezzuto J.M. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Res. 2001;61:7456\u20137463.", "ArticleIdList": ["11606380"]}, {"Citation": "Nguyen A.V., Martinez M., Stamos M.J., Moyer M.P., Planutis K., Hope C., Holcombe R.F. Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer. Cancer Manag. Res. 2009;1:25\u201337.", "ArticleIdList": ["PMC3004662", "21188121"]}, {"Citation": "Howells L.M., Berry D.P., Elliott P.J., Jacobson E.W., Hoffmann E., Hegarty B., Brown K., Steward W.P., Gescher A.J. Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics. Cancer Prev. Res. 2011;4:1419\u20131425. doi: 10.1158/1940-6207.CAPR-11-0148.", "ArticleIdList": ["10.1158/1940-6207.CAPR-11-0148", "PMC3173869", "21680702"]}, {"Citation": "Cottart C.H., Nivet-Antoine V., Laguillier-Morizot C., Beaudeux J.L. Resveratrol bioavailability and toxicity in humans. Mol. Nutr. Food Res. 2010;54:7\u201316. doi: 10.1002/mnfr.200900437.", "ArticleIdList": ["10.1002/mnfr.200900437", "20013887"]}, {"Citation": "Patel K.R., Scott E., Brown V.A., Gescher A.J., Steward W.P., Brown K. Clinical trials of resveratrol. Ann. N. Y. Acad. Sci. 2011;1215:161\u2013169. doi: 10.1111/j.1749-6632.2010.05853.x.", "ArticleIdList": ["10.1111/j.1749-6632.2010.05853.x", "21261655"]}, {"Citation": "Johnson J.J., Nihal M., Siddiqui I.A., Scarlett C.O., Bailey H.H., Mukhtar H., Ahmad N. Enhancing the bioavailability of resveratrol by combining it with piperine. Mol. Nutr. Food Res. 2011;55:1169\u20131176. doi: 10.1002/mnfr.201100117.", "ArticleIdList": ["10.1002/mnfr.201100117", "PMC3295233", "21714124"]}, {"Citation": "Pangeni R., Sahni J.K., Ali J., Sharma S., Baboota S. Resveratrol: Review on therapeutic potential and recent advances in drug delivery. Expert Opin. Drug Deliv. 2014;11:1285\u20131298. doi: 10.1517/17425247.2014.919253.", "ArticleIdList": ["10.1517/17425247.2014.919253", "24830814"]}, {"Citation": "Ansari K.A., Vavia P.R., Trotta F., Cavalli R. Cyclodextrin-based nanosponges for delivery of resveratrol: In vitro characterisation, stability, cytotoxicity and permeation study. AAPS Pharmscitech. 2011;12:279\u2013286. doi: 10.1208/s12249-011-9584-3.", "ArticleIdList": ["10.1208/s12249-011-9584-3", "PMC3066340", "21240574"]}, {"Citation": "Nastiti C., Ponto T., Mohammed Y., Roberts M.S., Benson H.A.E. Novel Nanocarriers for Targeted Topical Skin Delivery of the Antioxidant Resveratrol. Pharmaceutics. 2020;12:108. doi: 10.3390/pharmaceutics12020108.", "ArticleIdList": ["10.3390/pharmaceutics12020108", "PMC7076350", "32013204"]}, {"Citation": "Lee C.W., Yen F.L., Huang H.W., Wu T.H., Ko H.H., Tzeng W.S., Lin C.C. Resveratrol nanoparticle system improves dissolution properties and enhances the hepatoprotective effect of resveratrol through antioxidant and anti-inflammatory pathways. J. Agric. Food Chem. 2012;60:4662\u20134671. doi: 10.1021/jf2050137.", "ArticleIdList": ["10.1021/jf2050137", "22480310"]}, {"Citation": "Chaudhary Z., Subramaniam S., Khan G.M., Abeer M.M., Qu Z., Janjua T., Kumeria T., Batra J., Popat A. Encapsulation and Controlled Release of Resveratrol Within Functionalized Mesoporous Silica Nanoparticles for Prostate Cancer Therapy. Front. Bioeng. Biotechnol. 2019;7:225. doi: 10.3389/fbioe.2019.00225.", "ArticleIdList": ["10.3389/fbioe.2019.00225", "PMC6759778", "31620434"]}, {"Citation": "Summerlin N., Qu Z., Pujara N., Sheng Y., Jambhrunkar S., McGuckin M., Popat A. Colloidal mesoporous silica nanoparticles enhance the biological activity of resveratrol. Colloids Surf. B Biointerfaces. 2016;144:1\u20137. doi: 10.1016/j.colsurfb.2016.03.076.", "ArticleIdList": ["10.1016/j.colsurfb.2016.03.076", "27060664"]}, {"Citation": "Song D., Hao J., Fan D. Biological properties and clinical applications of berberine. Front. Med. 2020 doi: 10.1007/s11684-019-0724-6.", "ArticleIdList": ["10.1007/s11684-019-0724-6", "32335802"]}, {"Citation": "Cicero A.F., Baggioni A. Berberine and Its Role in Chronic Disease. Adv. Exp. Med. Biol. 2016;928:27\u201345. doi: 10.1007/978-3-319-41334-1_2.", "ArticleIdList": ["10.1007/978-3-319-41334-1_2", "27671811"]}, {"Citation": "Schor J., Fabno N. Clinical Applications for Berberine: Potential therapeutic applications in metabolic syndrome, type 2 diabetes, and dyslipidemia.  [(accessed on 1 January 2021)];Nat. Med. J. 2012 4 Available online:  https://www.naturalmedicinejournal.com/print/587."}, {"Citation": "Zych M., Wojnar W., Kielanowska M., Folwarczna J., Kaczmarczyk-Sedlak I. Effect of Berberine on Glycation, Aldose Reductase Activity, and Oxidative Stress in the Lenses of Streptozotocin-Induced Diabetic Rats In Vivo-A Preliminary Study. Int. J. Mol. Sci. 2020;21:4278. doi: 10.3390/ijms21124278.", "ArticleIdList": ["10.3390/ijms21124278", "PMC7349706", "32560082"]}, {"Citation": "Liu W., Liu P., Tao S., Deng Y., Li X., Lan T., Zhang X., Guo F., Huang W., Chen F., et al. Berberine inhibits aldose reductase and oxidative stress in rat mesangial cells cultured under high glucose. Arch. Biochem. Biophys. 2008;475:128\u2013134. doi: 10.1016/j.abb.2008.04.022.", "ArticleIdList": ["10.1016/j.abb.2008.04.022", "18471986"]}, {"Citation": "Zhu N., Li J., Li Y., Zhang Y., Du Q., Hao P., Cao X., Li L. Berberine Protects Against Simulated Ischemia/Reperfusion Injury-Induced H9C2 Cardiomyocytes Apoptosis In Vitro and Myocardial Ischemia/Reperfusion-Induced Apoptosis In Vivo by Regulating the Mitophagy-Mediated HIF-1\u03b1/BNIP3 Pathway. Front. Pharm. 2020;11:367. doi: 10.3389/fphar.2020.00367.", "ArticleIdList": ["10.3389/fphar.2020.00367", "PMC7120539", "32292345"]}, {"Citation": "Zhao G.L., Yu L.M., Gao W.L., Duan W.X., Jiang B., Liu X.D., Zhang B., Liu Z.H., Zhai M.E., Jin Z.X., et al. Berberine protects rat heart from ischemia/reperfusion injury via activating JAK2/STAT3 signaling and attenuating endoplasmic reticulum stress. Acta Pharm. Sin. 2016;37:354\u2013367. doi: 10.1038/aps.2015.136.", "ArticleIdList": ["10.1038/aps.2015.136", "PMC4775848", "26806299"]}, {"Citation": "Kuo C.-L., Chi C.-W., Liu T.-Y. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett. 2004;203:127\u2013137. doi: 10.1016/j.canlet.2003.09.002.", "ArticleIdList": ["10.1016/j.canlet.2003.09.002", "14732220"]}, {"Citation": "Wang Y., Yi X., Ghanam K., Zhang S., Zhao T., Zhu X. Berberine decreases cholesterol levels in rats through multiple mechanisms, including inhibition of cholesterol absorption. Metabolism. 2014;63:1167\u20131177. doi: 10.1016/j.metabol.2014.05.013.", "ArticleIdList": ["10.1016/j.metabol.2014.05.013", "25002181"]}, {"Citation": "Xu J., Long Y., Ni L., Yuan X., Yu N., Wu R., Tao J., Zhang Y. Anticancer effect of berberine based on experimental animal models of various cancers: A systematic review and meta-analysis. BMC Cancer. 2019;19:589. doi: 10.1186/s12885-019-5791-1.", "ArticleIdList": ["10.1186/s12885-019-5791-1", "PMC6580644", "31208348"]}, {"Citation": "Yin J., Xing H., Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metab. Clin. Exp. 2008;57:712\u2013717. doi: 10.1016/j.metabol.2008.01.013.", "ArticleIdList": ["10.1016/j.metabol.2008.01.013", "PMC2410097", "18442638"]}, {"Citation": "Cicero A., Ertek S. Metabolic and cardiovascular effects of berberine: From preclinical evidences to clinical trial results. Clin. Lipidol. 2009;4:553\u2013563. doi: 10.2217/clp.09.41.", "ArticleIdList": ["10.2217/clp.09.41"]}, {"Citation": "Cicero A.F.G., Colletti A. Role of phytochemicals in the management of metabolic syndrome. Phytomedicine. 2016;23:1134\u20131144. doi: 10.1016/j.phymed.2015.11.009.", "ArticleIdList": ["10.1016/j.phymed.2015.11.009", "26778479"]}, {"Citation": "Cristiana C., Placido F., Silvia S., Aldo Roda and Arrigo F.G.C. Berberine: New Insights from Pharmacological Aspects to Clinical Evidences in the Management of Metabolic Disorders. Curr. Med. Chem. 2016;23:1460\u20131476. doi: 10.2174/0929867323666160411143314.", "ArticleIdList": ["10.2174/0929867323666160411143314", "27063256"]}, {"Citation": "Wang Y., Liu Y., Du X., Ma H., Yao J. The Anti-Cancer Mechanisms of Berberine: A Review. Cancer Manag. Res. 2020;12:695\u2013702. doi: 10.2147/CMAR.S242329.", "ArticleIdList": ["10.2147/CMAR.S242329", "PMC6996556", "32099466"]}, {"Citation": "Sahibzada M.U.K., Sadiq A., Faidah H.S., Khurram M., Amin M.U., Haseeb A., Kakar M. Berberine nanoparticles with enhanced in vitro bioavailability: Characterization and antimicrobial activity. Drug Des. Dev. Ther. 2018;12:303\u2013312. doi: 10.2147/DDDT.S156123.", "ArticleIdList": ["10.2147/DDDT.S156123", "PMC5817421", "29491706"]}, {"Citation": "Mirhadi E., Rezaee M., Malaekeh-Nikouei B. Nano strategies for berberine delivery, a natural alkaloid of Berberis. Biomed. Pharm. 2018;104:465\u2013473. doi: 10.1016/j.biopha.2018.05.067.", "ArticleIdList": ["10.1016/j.biopha.2018.05.067", "29793179"]}, {"Citation": "Deng J., Wu Z., Zhao Z., Wu C., Yuan M., Su Z., Wang Y., Wang Z. Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis. Int. J. Nanomed. 2020;15:3937\u20133951. doi: 10.2147/IJN.S247406.", "ArticleIdList": ["10.2147/IJN.S247406", "PMC7280064", "32581538"]}, {"Citation": "Yue J., Wang Z., Shao D., Chang Z., Hu R., Li L., Luo S.-Z., Dong W.-F. Cancer cell membrane-modified biodegradable mesoporous silica nanocarriers for berberine therapy of liver cancer. RSC Adv. 2018;8:40288\u201340297. doi: 10.1039/C8RA07574C.", "ArticleIdList": ["10.1039/C8RA07574C", "PMC9091357", "35558223"]}, {"Citation": "Schneider-Stock R., Fakhoury I.H., Zaki A.M., El-Baba C.O., Gali-Muhtasib H.U. Thymoquinone: Fifty years of success in the battle against cancer models. Drug Discov. Today. 2014;19:18\u201330. doi: 10.1016/j.drudis.2013.08.021.", "ArticleIdList": ["10.1016/j.drudis.2013.08.021", "24001594"]}, {"Citation": "Gurung R.L., Lim S.N., Khaw A.K., Soon J.F., Shenoy K., Mohamed Ali S., Jayapal M., Sethu S., Baskar R., Hande M.P. Thymoquinone induces telomere shortening, DNA damage and apoptosis in human glioblastoma cells. PLoS ONE. 2010;5:e12124. doi: 10.1371/journal.pone.0012124.", "ArticleIdList": ["10.1371/journal.pone.0012124", "PMC2920825", "20711342"]}, {"Citation": "Gali-Muhtasib H., Ocker M., Kuester D., Krueger S., El-Hajj Z., Diestel A., Evert M., El-Najjar N., Peters B., Jurjus A., et al. Thymoquinone reduces mouse colon tumor cell invasion and inhibits tumor growth in murine colon cancer models. J. Cell Mol. Med. 2008;12:330\u2013342. doi: 10.1111/j.1582-4934.2007.00095.x.", "ArticleIdList": ["10.1111/j.1582-4934.2007.00095.x", "PMC3823493", "18366456"]}, {"Citation": "Jakaria M., Cho D.Y., Ezazul Haque M., Karthivashan G., Kim I.S., Ganesan P., Choi D.K. Neuropharmacological Potential and Delivery Prospects of Thymoquinone for Neurological Disorders. Oxid. Med. Cell. Longev. 2018;2018:1209801. doi: 10.1155/2018/1209801.", "ArticleIdList": ["10.1155/2018/1209801", "PMC5883931", "29743967"]}, {"Citation": "Ahmad A., Mishra R.K., Vyawahare A., Kumar A., Rehman M.U., Qamar W., Khan A.Q., Khan R. Thymoquinone (2-Isoprpyl-5-methyl-1, 4-benzoquinone) as a chemopreventive/anticancer agent: Chemistry and biological effects. Saudi Pharm. J. 2019;27:1113\u20131126. doi: 10.1016/j.jsps.2019.09.008.", "ArticleIdList": ["10.1016/j.jsps.2019.09.008", "PMC6921197", "31885471"]}, {"Citation": "Al-Majed A.A., Al-Omar F.A., Nagi M.N. Neuroprotective effects of thymoquinone against transient forebrain ischemia in the rat hippocampus. Eur. J. Pharmacol. 2006;543:40\u201347. doi: 10.1016/j.ejphar.2006.05.046.", "ArticleIdList": ["10.1016/j.ejphar.2006.05.046", "16828080"]}, {"Citation": "Umar S., Zargan J., Umar K., Ahmad S., Katiyar C.K., Khan H.A. Modulation of the oxidative stress and inflammatory cytokine response by thymoquinone in the collagen induced arthritis in Wistar rats. Chem. Biol. Interact. 2012;197:40\u201346. doi: 10.1016/j.cbi.2012.03.003.", "ArticleIdList": ["10.1016/j.cbi.2012.03.003", "22450443"]}, {"Citation": "Woo C.C., Kumar A.P., Sethi G., Tan K.H.B. Thymoquinone: Potential cure for inflammatory disorders and cancer. Biochem. Pharmacol. 2012;83:443\u2013451. doi: 10.1016/j.bcp.2011.09.029.", "ArticleIdList": ["10.1016/j.bcp.2011.09.029", "22005518"]}, {"Citation": "Asaduzzaman Khan M., Tania M., Fu S., Fu J. Thymoquinone, as an anticancer molecule: From basic research to clinical investigation. Oncotarget. 2017;8:51907\u201351919. doi: 10.18632/oncotarget.17206.", "ArticleIdList": ["10.18632/oncotarget.17206", "PMC5584300", "28881699"]}, {"Citation": "Chaieb K., Kouidhi B., Jrah H., Mahdouani K., Bakhrouf A. Antibacterial activity of Thymoquinone, an active principle of Nigella sativa and its potency to prevent bacterial biofilm formation. BMC Complement. Altern. Med. 2011;11:29. doi: 10.1186/1472-6882-11-29.", "ArticleIdList": ["10.1186/1472-6882-11-29", "PMC3095572", "21489272"]}, {"Citation": "Kassab R.B., El-Hennamy R.E. The role of thymoquinone as a potent antioxidant in ameliorating the neurotoxic effect of sodium arsenate in female rat. Egypt. J. Basic Appl. Sci. 2017;4:160\u2013167. doi: 10.1016/j.ejbas.2017.07.002.", "ArticleIdList": ["10.1016/j.ejbas.2017.07.002"]}, {"Citation": "Bule M., Nikfar S., Amini M., Abdollahi M. The antidiabetic effect of thymoquinone: A systematic review and meta-analysis of animal studies. Food Res. Int. 2020;127:108736. doi: 10.1016/j.foodres.2019.108736.", "ArticleIdList": ["10.1016/j.foodres.2019.108736", "31882078"]}, {"Citation": "El-Najjar N., Ketola R.A., Nissil\u00e4 T., Mauriala T., Antopolsky M., J\u00e4nis J., Gali-Muhtasib H., Urtti A., Vuorela H. Impact of protein binding on the analytical detectability and anticancer activity of thymoquinone. J. Chem. Biol. 2011;4:97\u2013107. doi: 10.1007/s12154-010-0052-4.", "ArticleIdList": ["10.1007/s12154-010-0052-4", "PMC3124627", "22229047"]}, {"Citation": "Pathan S.A., Jain G.K., Zaidi S.M., Akhter S., Vohora D., Chander P., Kole P.L., Ahmad F.J., Khar R.K. Stability-indicating ultra-performance liquid chromatography method for the estimation of thymoquinone and its application in biopharmaceutical studies. Biomed. Chromatogr. 2011;25:613\u2013620. doi: 10.1002/bmc.1492.", "ArticleIdList": ["10.1002/bmc.1492", "20734352"]}, {"Citation": "Salmani J.M., Asghar S., Lv H., Zhou J. Aqueous solubility and degradation kinetics of the phytochemical anticancer thymoquinone; probing the effects of solvents, pH and light. Molecules. 2014;19:5925\u20135939. doi: 10.3390/molecules19055925.", "ArticleIdList": ["10.3390/molecules19055925", "PMC6270770", "24815311"]}, {"Citation": "Darakhshan S., Bidmeshki Pour A., Hosseinzadeh Colagar A., Sisakhtnezhad S. Thymoquinone and its therapeutic potentials. Pharm. Res. 2015;95\u201396:138\u2013158. doi: 10.1016/j.phrs.2015.03.011.", "ArticleIdList": ["10.1016/j.phrs.2015.03.011", "25829334"]}, {"Citation": "Rathore C., Upadhyay N., Kaundal R., Dwivedi R.P., Rahatekar S., John A., Dua K., Tambuwala M.M., Jain S., Chaudari D., et al. Enhanced oral bioavailability and hepatoprotective activity of thymoquinone in the form of phospholipidic nano-constructs. Expert Opin. Drug Deliv. 2020;17:237\u2013253. doi: 10.1080/17425247.2020.1716728.", "ArticleIdList": ["10.1080/17425247.2020.1716728", "32003249"]}, {"Citation": "Abukhader M.M., Khan S.A. Thymoquinone and Nanoparticles: A Promising Approach for the Clinical Trials. J. Bionanosci. 2017;11:258\u2013265. doi: 10.1166/jbns.2017.1447.", "ArticleIdList": ["10.1166/jbns.2017.1447"]}, {"Citation": "Goel S., Mishra P. Thymoquinone loaded mesoporous silica nanoparticles retard cell invasion and enhance in vitro cytotoxicity due to ROS mediated apoptosis in HeLa and MCF-7 cell lines. Mater. Sci. Eng. C Mater. Biol. Appl. 2019;104:109881. doi: 10.1016/j.msec.2019.109881.", "ArticleIdList": ["10.1016/j.msec.2019.109881", "31499940"]}, {"Citation": "Fahmy H.M., Fathy M.M., Abd-elbadia R.A., Elshemey W.M. Targeting of Thymoquinone-loaded mesoporous silica nanoparticles to different brain areas: In vivo study. Life Sci. 2019;222:94\u2013102. doi: 10.1016/j.lfs.2019.02.058.", "ArticleIdList": ["10.1016/j.lfs.2019.02.058", "30826496"]}, {"Citation": "Kahkeshani N., Farzaei F., Fotouhi M., Alavi S.S., Bahramsoltani R., Naseri R., Momtaz S., Abbasabadi Z., Rahimi R., Farzaei M.H., et al. Pharmacological effects of gallic acid in health and diseases: A mechanistic review. Iran. J. Basic Med. Sci. 2019;22:225\u2013237. doi: 10.22038/ijbms.2019.32806.7897.", "ArticleIdList": ["10.22038/ijbms.2019.32806.7897", "PMC6528712", "31156781"]}, {"Citation": "Li Z.-J., Liu M., Dawuti G., Dou Q., Ma Y., Liu H.-G., Aibai S. Antifungal Activity of Gallic Acid In Vitro and In Vivo. Phytother. Res. 2017;31:1039\u20131045. doi: 10.1002/ptr.5823.", "ArticleIdList": ["10.1002/ptr.5823", "28524381"]}, {"Citation": "Subramanian A.P., John A.A., Vellayappan M.V., Balaji A., Jaganathan S.K., Supriyanto E., Yusof M. Gallic acid: Prospects and molecular mechanisms of its anticancer activity. RSC Adv. 2015;5:35608\u201335621. doi: 10.1039/C5RA02727F.", "ArticleIdList": ["10.1039/C5RA02727F"]}, {"Citation": "Akbari G. Molecular mechanisms underlying gallic acid effects against cardiovascular diseases: An update review. Avicenna J. Phytomed. 2020;10:11\u201323.", "ArticleIdList": ["PMC6941690", "31921604"]}, {"Citation": "Gao J., Hu J., Hu D., Yang X. A Role of Gallic Acid in Oxidative Damage Diseases: A Comprehensive Review. Nat. Prod. Commun. 2019;14:1934578X19874174. doi: 10.1177/1934578X19874174.", "ArticleIdList": ["10.1177/1934578X19874174"]}, {"Citation": "Shabani S., Rabiei Z., Amini-Khoei H. Exploring the multifaceted neuroprotective actions of gallic acid: A review. Int. J. Food Prop. 2020;23:736\u2013752. doi: 10.1080/10942912.2020.1753769.", "ArticleIdList": ["10.1080/10942912.2020.1753769"]}, {"Citation": "Badhani B., Sharma N., Kakkar R. Gallic acid: A versatile antioxidant with promising therapeutic and industrial applications. RSC Adv. 2015;5:27540\u201327557. doi: 10.1039/C5RA01911G.", "ArticleIdList": ["10.1039/C5RA01911G"]}, {"Citation": "de Cristo Soares Alves A., Mainardes R.M., Khalil N.M. Nanoencapsulation of gallic acid and evaluation of its cytotoxicity and antioxidant activity. Mater. Sci. Eng. C Mater. Biol. Appl. 2016;60:126\u2013134. doi: 10.1016/j.msec.2015.11.014.", "ArticleIdList": ["10.1016/j.msec.2015.11.014", "26706515"]}, {"Citation": "Khan B.A., Mahmood T., Menaa F., Shahzad Y., Yousaf A.M., Hussain T., Ray S.D. New Perspectives on the Efficacy of Gallic Acid in Cosmetics & Nanocosmeceuticals. Curr. Pharm. Des. 2018;24:5181\u20135187. doi: 10.2174/1381612825666190118150614.", "ArticleIdList": ["10.2174/1381612825666190118150614", "30657034"]}, {"Citation": "Zhao Y., Li D., Zhu Z., Sun Y. Improved Neuroprotective Effects of Gallic Acid-Loaded Chitosan Nanoparticles Against Ischemic Stroke. Rejuvenation Res. 2019;23:284\u2013292. doi: 10.1089/rej.2019.2230.", "ArticleIdList": ["10.1089/rej.2019.2230", "31680647"]}, {"Citation": "Shah S.T., Yehya W.A., Saad O., Simarani K., Chowdhury Z., Alhadi A.A., Al-Ani L.A. Surface Functionalization of Iron Oxide Nanoparticles with Gallic Acid as Potential Antioxidant and Antimicrobial Agents. Nanomaterials. 2017;7:306. doi: 10.3390/nano7100306.", "ArticleIdList": ["10.3390/nano7100306", "PMC5666471", "28981476"]}, {"Citation": "Nagpal K., Singh S.K., Mishra D.N. Nanoparticle mediated brain targeted delivery of gallic acid: In vivo behavioral and biochemical studies for improved antioxidant and antidepressant-like activity. Drug Deliv. 2012;19:378\u2013391. doi: 10.3109/10717544.2012.738437.", "ArticleIdList": ["10.3109/10717544.2012.738437", "23173579"]}, {"Citation": "Lewandowski D., Ruszkowski P., Pi\u0144ska A., Schroeder G., Kurczewska J. SBA-15 Mesoporous Silica Modified with Gallic Acid and Evaluation of Its Cytotoxic Activity. PLoS ONE. 2015;10:e0132541. doi: 10.1371/journal.pone.0132541.", "ArticleIdList": ["10.1371/journal.pone.0132541", "PMC4495030", "26151908"]}, {"Citation": "Rashidi L., Vasheghani-Farahani E., Soleimani M., Atashi A., Rostami K., Gangi F., Fallahpour M., Tahouri M.T. A cellular uptake and cytotoxicity properties study of gallic acid-loaded mesoporous silica nanoparticles on Caco-2 cells. J. Nanopart. Res. 2014;16:2285. doi: 10.1007/s11051-014-2285-6.", "ArticleIdList": ["10.1007/s11051-014-2285-6"]}, {"Citation": "Lammari N., Louaer O., Meniai A.H., Elaissari A. Encapsulation of Essential Oils via Nanoprecipitation Process: Overview, Progress, Challenges and Prospects. Pharmaceutics. 2020;12:431. doi: 10.3390/pharmaceutics12050431.", "ArticleIdList": ["10.3390/pharmaceutics12050431", "PMC7284627", "32392726"]}, {"Citation": "Sharifi-Rad J., Sureda A., Tenore G.C., Daglia M., Sharifi-Rad M., Valussi M., Tundis R., Loizzo M.R., Ademiluyi A.O., Sharifi-Rad R., et al. Biological Activities of Essential Oils: From Plant Chemoecology to Traditional Healing Systems. Molecules. 2017;22:70. doi: 10.3390/molecules22010070.", "ArticleIdList": ["10.3390/molecules22010070", "PMC6155610", "28045446"]}, {"Citation": "Elshafie H.S., Camele I. An Overview of the Biological Effects of Some Mediterranean Essential Oils on Human Health. BioMed Res. Int. 2017;2017:9268468. doi: 10.1155/2017/9268468.", "ArticleIdList": ["10.1155/2017/9268468", "PMC5694587", "29230418"]}, {"Citation": "Baser K.H.C., Buchbauer G. Handbook of Essential Oils: Science, Technology, and Applications. CRC Press; Boca Raton, FL, USA: 2015."}, {"Citation": "Ali B., Al-Wabel N.A., Shams S., Ahamad A., Khan S.A., Anwar F. Essential oils used in aromatherapy: A systemic review. Asian Pac. J. Trop. Biomed. 2015;5:601\u2013611. doi: 10.1016/j.apjtb.2015.05.007.", "ArticleIdList": ["10.1016/j.apjtb.2015.05.007"]}, {"Citation": "Dhifi W., Bellili S., Jazi S., Bahloul N., Mnif W. Essential Oils\u2019 Chemical Characterization and Investigation of Some Biological Activities: A Critical Review. Medicines. 2016;3:25. doi: 10.3390/medicines3040025.", "ArticleIdList": ["10.3390/medicines3040025", "PMC5456241", "28930135"]}, {"Citation": "Andrade M.A., Braga M.A., Cesar P.H.S., Trento M.V.C., Esp\u00f3sito M.A., Silva L.F., Marcussi S. Anticancer Properties of Essential Oils: An Overview. Curr. Cancer Drug Targets. 2018;18:957\u2013966. doi: 10.2174/1568009618666180102105843.", "ArticleIdList": ["10.2174/1568009618666180102105843", "29295695"]}, {"Citation": "Edris A.E. Pharmaceutical and therapeutic Potentials of essential oils and their individual volatile constituents: A review. Phytother. Res. 2007;21:308\u2013323. doi: 10.1002/ptr.2072.", "ArticleIdList": ["10.1002/ptr.2072", "17199238"]}, {"Citation": "Blowman K., Magalh\u00e3es M., Lemos M.F.L., Cabral C., Pires I.M. Anticancer Properties of Essential Oils and Other Natural Products. Evid.-Based Complement. Altern. Med. 2018;2018:3149362. doi: 10.1155/2018/3149362.", "ArticleIdList": ["10.1155/2018/3149362", "PMC5889900", "29765461"]}, {"Citation": "Gautam N., Mantha A.K., Mittal S. Essential Oils and Their Constituents as Anticancer Agents: A Mechanistic View. BioMed Res. Int. 2014;2014:154106. doi: 10.1155/2014/154106.", "ArticleIdList": ["10.1155/2014/154106", "PMC4070586", "25003106"]}, {"Citation": "Fitsiou E., Pappa A. Anticancer Activity of Essential Oils and Other Extracts from Aromatic Plants Grown in Greece. Antioxidants. 2019;8:290. doi: 10.3390/antiox8080290.", "ArticleIdList": ["10.3390/antiox8080290", "PMC6720353", "31394842"]}, {"Citation": "Bhalla Y., Gupta V.K., Jaitak V. Anticancer activity of essential oils: A review. J. Sci. Food Agric. 2013;93:3643\u20133653. doi: 10.1002/jsfa.6267.", "ArticleIdList": ["10.1002/jsfa.6267", "23765679"]}, {"Citation": "Bayala B., Bassole I.H., Scifo R., Gnoula C., Morel L., Lobaccaro J.-M.A., Simpore J. Anticancer activity of essential oils and their chemical components\u2014A review. Am. J. Cancer Res. 2014;4:591\u2013607.", "ArticleIdList": ["PMC4266698", "25520854"]}, {"Citation": "Manjamalai A., Kumar M.J., Grace V.M. Essential oil of Tridax procumbens L induces apoptosis and suppresses angiogenesis and lung metastasis of the B16F-10 cell line in C57BL/6 mice. Asian Pac. J. Cancer Prev. 2012;13:5887\u20135895. doi: 10.7314/APJCP.2012.13.11.5887.", "ArticleIdList": ["10.7314/APJCP.2012.13.11.5887", "23317275"]}, {"Citation": "Manjamalai A., Grace V.M. The chemotherapeutic effect of essential oil of Plectranthus amboinicus (Lour) on lung metastasis developed by B16F-10 cell line in C57BL/6 mice. Cancer Investig. 2013;31:74\u201382. doi: 10.3109/07357907.2012.749268.", "ArticleIdList": ["10.3109/07357907.2012.749268", "23249189"]}, {"Citation": "Turek C., Stintzing F.C. Stability of Essential Oils: A Review. Compr. Rev. Food Sci. Food Saf. 2013;12:40\u201353. doi: 10.1111/1541-4337.12006.", "ArticleIdList": ["10.1111/1541-4337.12006"]}, {"Citation": "Froiio F., Ginot L., Paolino D., Lebaz N., Bentaher A., Fessi H., Elaissari A. Essential Oils-Loaded Polymer Particles: Preparation, Characterization and Antimicrobial Property. Polymers. 2019;11:17. doi: 10.3390/polym11061017.", "ArticleIdList": ["10.3390/polym11061017", "PMC6630521", "31181851"]}, {"Citation": "Ali H., Al-Khalifa A.R., Aouf A., Boukhebti H., Farouk A. Effect of nanoencapsulation on volatile constituents, and antioxidant and anticancer activities of Algerian Origanum glandulosum Desf. essential oil. Sci. Rep. 2020;10:2812. doi: 10.1038/s41598-020-59686-w.", "ArticleIdList": ["10.1038/s41598-020-59686-w", "PMC7028938", "32071359"]}, {"Citation": "Attallah O.A., Shetta A., Elshishiny F., Mamdouh W. Essential oil loaded pectin/chitosan nanoparticles preparation and optimization via Box\u2013Behnken design against MCF-7 breast cancer cell lines. RSC Adv. 2020;10:8703\u20138708. doi: 10.1039/C9RA10204C.", "ArticleIdList": ["10.1039/C9RA10204C", "PMC9049973", "35496538"]}, {"Citation": "De Matos S.P., Teixeira H.F., de Lima \u00c1.A.N., Veiga-Junior V.F., Koester L.S. Essential Oils and Isolated Terpenes in Nanosystems Designed for Topical Administration: A Review. Biomolecules. 2019;9:138. doi: 10.3390/biom9040138.", "ArticleIdList": ["10.3390/biom9040138", "PMC6523335", "30959802"]}, {"Citation": "Melendez-Rodriguez B., Figueroa-Lopez K.J., Bernardos A., Mart\u00ednez-M\u00e1\u00f1ez R., Cabedo L., Torres-Giner S., Lagaron J.M. Electrospun Antimicrobial Films of Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) Containing Eugenol Essential Oil Encapsulated in Mesoporous Silica Nanoparticles. Nanomaterials. 2019;9:227. doi: 10.3390/nano9020227.", "ArticleIdList": ["10.3390/nano9020227", "PMC6409543", "30744000"]}, {"Citation": "Ebadollahi A., Sendi J.J., Aliakbar A. Efficacy of Nanoencapsulated Thymus eriocalyx and Thymus kotschyanus Essential Oils by a Mesoporous Material MCM-41 Against Tetranychus urticae (Acari: Tetranychidae) J. Econ. Entomol. 2017;110:2413\u20132420. doi: 10.1093/jee/tox234.", "ArticleIdList": ["10.1093/jee/tox234", "29029248"]}, {"Citation": "Janatova A., Bernardos A., Smid J., Frankova A., Lhotka M., Kourimsk\u00e1 L., Pulkrabek J., Kloucek P. Long-term antifungal activity of volatile essential oil components released from mesoporous silica materials. Ind. Crop. Prod. 2015;67:216\u2013220. doi: 10.1016/j.indcrop.2015.01.019.", "ArticleIdList": ["10.1016/j.indcrop.2015.01.019"]}, {"Citation": "Jobdeedamrong A., Jenjob R., Crespy D. Encapsulation and Release of Essential Oils in Functional Silica Nanocontainers. Langmuir. 2018;34:13235\u201313243. doi: 10.1021/acs.langmuir.8b01652.", "ArticleIdList": ["10.1021/acs.langmuir.8b01652", "30300551"]}, {"Citation": "Kim M., Yeom Y.E., Kim D., Kim J., Lee C. Delayed Volatilization of Lavender Essential Oil Using Mesoporous Silica Nanoparticles. Polymer. 2019;43:327\u2013330. doi: 10.7317/pk.2019.43.3.327.", "ArticleIdList": ["10.7317/pk.2019.43.3.327"]}, {"Citation": "Jin L., Teng J., Hu L., Lan X., Xu Y., Sheng J., Song Y., Wang M. Pepper fragrant essential oil (PFEO) and functionalized MCM-41 nanoparticles: Formation, characterization, and bactericidal activity. J. Sci. Food Agric. 2019;99:5168\u20135175. doi: 10.1002/jsfa.9776.", "ArticleIdList": ["10.1002/jsfa.9776", "31056749"]}, {"Citation": "Bravo Cadena M., Preston G.M., Van der Hoorn R.A.L., Townley H.E., Thompson I.P. Species-specific antimicrobial activity of essential oils and enhancement by encapsulation in mesoporous silica nanoparticles. Ind. Crop. Prod. 2018;122:582\u2013590. doi: 10.1016/j.indcrop.2018.05.081.", "ArticleIdList": ["10.1016/j.indcrop.2018.05.081"]}, {"Citation": "Bernardos A., Marina T., \u017d\u00e1\u010dek P., P\u00e9rez-Esteve \u00c9., Mart\u00ednez-Ma\u00f1ez R., Lhotka M., Kou\u0159imsk\u00e1 L., Pulkr\u00e1bek J., Klou\u010dek P. Antifungal effect of essential oil components against Aspergillus niger when loaded into silica mesoporous supports. J. Sci. Food Agric. 2015;95:2824\u20132831. doi: 10.1002/jsfa.7022.", "ArticleIdList": ["10.1002/jsfa.7022", "25428206"]}, {"Citation": "Chan A.C., Bravo Cadena M., Townley H.E., Fricker M.D., Thompson I.P. Effective delivery of volatile biocides employing mesoporous silicates for treating biofilms. J. R. Soc. Interface. 2017;14:20160650. doi: 10.1098/rsif.2016.0650.", "ArticleIdList": ["10.1098/rsif.2016.0650", "PMC5310729", "28077760"]}, {"Citation": "Crespo-Ortiz M.P., Wei M.Q. Antitumor activity of artemisinin and its derivatives: From a well-known antimalarial agent to a potential anticancer drug. J. Biomed. Biotechnol. 2012;2012:247597. doi: 10.1155/2012/247597.", "ArticleIdList": ["10.1155/2012/247597", "PMC3228295", "22174561"]}, {"Citation": "Chen J., Guo Z., Wang H.B., Zhou J.J., Zhang W.J., Chen Q.W. Multifunctional mesoporous nanoparticles as pH-responsive Fe(2+) reservoirs and artemisinin vehicles for synergistic inhibition of tumor growth. Biomaterials. 2014;35:6498\u20136507. doi: 10.1016/j.biomaterials.2014.04.028.", "ArticleIdList": ["10.1016/j.biomaterials.2014.04.028", "24797880"]}, {"Citation": "Kumar A., Sharma P.R., Mondhe D.M. Potential anticancer role of colchicine-based derivatives: An overview. Anticancer Drugs. 2017;28:250\u2013262. doi: 10.1097/CAD.0000000000000464.", "ArticleIdList": ["10.1097/CAD.0000000000000464", "28030380"]}, {"Citation": "Cauda V., Engelke H., Sauer A., Arcizet D., Br\u00e4uchle C., R\u00e4dler J., Bein T. Colchicine-Loaded Lipid Bilayer-Coated 50 nm Mesoporous Nanoparticles Efficiently Induce Microtubule Depolymerization upon Cell Uptake. Nano Lett. 2010;10:2484\u20132492. doi: 10.1021/nl100991w.", "ArticleIdList": ["10.1021/nl100991w", "20515041"]}, {"Citation": "Hespeler D., Kaltenbach J., Pyo S.M. Glabridin smartPearls\u2014Silica selection, production, amorphous stability and enhanced solubility. Int. J. Pharm. 2019;561:228\u2013235. doi: 10.1016/j.ijpharm.2019.02.028.", "ArticleIdList": ["10.1016/j.ijpharm.2019.02.028", "30836152"]}, {"Citation": "Buda V., Brezoiu A.M., Berger D., Pavel I.Z., Muntean D., Minda D., Dehelean C.A., Soica C., Diaconeasa Z., Folescu R., et al. Biological Evaluation of Black Chokeberry Extract Free and Embedded in Two Mesoporous Silica-Type Matrices. Pharmaceutics. 2020;12:838. doi: 10.3390/pharmaceutics12090838.", "ArticleIdList": ["10.3390/pharmaceutics12090838", "PMC7558869", "32882983"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "11", "Day": "30"}, {"Year": "2021", "Month": "1", "Day": "12"}, {"Year": "2021", "Month": "1", "Day": "14"}, {"Year": "2021", "Month": "1", "Day": "27", "Hour": "1", "Minute": "8"}, {"Year": "2021", "Month": "1", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "1", "Day": "28", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "1", "Day": "22"}], "PublicationStatus": "epublish", "ArticleIdList": ["33499150", "PMC7912645", "10.3390/pharmaceutics13020143", "pharmaceutics13020143"]}}], "PubmedBookArticle": []}